Metalation and Demetalation of Human Metallothionein Studied by Ion Mobility Mass Spectrometry by Chen, Shu-Hua
  
 
METALATION AND DEMETALATION OF HUMAN METALLOTHIONEIN 
STUDIED BY ION MOBILITY MASS SPECTROMETRY 
 
 
A Dissertation 
by 
SHU-HUA CHEN  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
Chair of Committee,  David H. Russell 
Committee Members, Tadhg P. Begley 
 James C. Hu 
 Emile A. Schweikert  
Head of Department, Francois P. Gabbai  
 
May 2015 
 
Major Subject: Chemistry 
 
Copyright: May 2015 Shu-Hua Chen
 ii 
 
ABSTRACT 
 
The mechanism of cadmium binding to intact human metallothionein-2A (MT) is 
investigated. We describe two complementary mass spectrometry (MS) strategies to 
study the metalation/demetalation mechanism: (i) chemical labeling combined with 
proteomics-based top-down or bottom-up approaches (ii) ion mobility-mass 
spectrometry (IM-MS).  We presented here for the first time for direct identification of 
metal-binding sites on a partially-metalated intermediates by combing chemical 
modifications (N-ethylmaleimide (NEM)) and 2D MS-CID-IM-MS. These results 
provide conclusive evidence of specific binding of Cd
2+
 to the -domain and 
demetalation is the reverse order of metalation. Molecular-specific profiles for metal 
affinity and kinetic stability for each metalated intermediate provided by MS reveal that 
the reactivity of various CdiMT species is dependent on their metalation state and 
reaction is cooperative for both domains. These data suggest that the -domain has 
greater thermodynamic/kinetic stability than does the -domain.  In addition, the 
alkylation on kinetically labile cysteins reveals that the α domain contains a weakly 
coordinated site at Cys33, which is located at the extreme N terminus of the α domain 
and might be related to the intra-domain cooperativity.  
Further, IM-MS and molecular dynamics (MD) simulations are used to follow 
metal-induced conformational changes, which reveal new insights into the mechanism 
for metalation of MT.  IM data for the CdiMT (i = 0 − 7) ions reveal a diverse population 
of ion conformations. Upon metal-ion binding, the conformational diversity for apoMT 
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and partially-metalated ions converges toward ordered, compact conformations as the 
number of bound Cd
2+
 ions increase. We interpret this data as evidence of metal-
dependent folding and increasing numbers of metal ions yield more compact ion 
structures. MD simulations provide additional information on conformation candidates 
of CdiMT (i = 0 − 7) that supports the convergence of distinct conformational 
populations upon metal binding. Integrating the IM-MS and MD data provides a global 
view that shows stepwise conformational transition of an ensemble as a function of 
metal ion bound. Furthermore, collisional activation was used to increase effective ion 
temperature (Teff) prior to entering and within the ion mobility analyzer, providing new 
insights about protein folding energy landscape.  
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NOMENCLATURE 
 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
ESI Electrospray ionization 
FRET Fluorescence resonance energy transfer 
HDX Hydrogen-deuterium exchange 
IM Ion mobility 
MD Molecular dynamics 
MS Mass spectrometry 
MT Metallothionein 
NEM N-ethylmaleimide 
SAXS Small-angle X-ray scattering 
TCEP Tris(2-carboxyethyl)phosphine 
Teff Effective ion temperature 
TW   Traveling wave  
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CHAPTER I 
 INTRODUCTION 
 
 Metal ions play important roles in many chemical and biochemical processes, 
such as oxidation, oxygen transport, and electron transfer; almost half of the known 
enzymes require a specific metal to function. Metallothioneins (MTs) represent a family 
of cysteine-rich, small (~ 6  7 kDa) proteins.1  MTs have been isolated from a wide 
range of living systems, including bacteria to human, suggesting that they play essential 
roles in biological systems.  Homo sapiens contains at least 17 different MT isoforms.
2-3
 
Based on their sequence similarities and phylogenetic relationships, they are divided into 
4 classes. MT-1 and MT-2 isoforms widely expressed in most organs. MT-3 is found 
predominately in brain and MT-4 is only detected in differentiating stratified squamous 
epithelia and the maternal deciduum.
2,4
  One of the most studied isoform, human MT-2A 
is a monomeric protein composed of 61 amino acid residues of which twenty are 
cysteines (Figure 1.1). The cysteines coordinate to a wide variety of metal ions, 
including essential metal ions such as Cu
+
 and Zn
2+
 and nonessential metal ions such as 
Cd
2+
 and Hg
2+
. Seven divalent or twelve monovalent metal ions are bound by the 
thiolates of MT with metal affinity in this order: Hg
2+
 > Cu
+
 > Cd
2+
 > Zn
2+
, consistent 
with their Hard and Soft Acids and Bases (HSAB) properties.  Although MT-metal ions 
complexes are thermodynamically stable, the metal-thiolate bonds are kinetically very 
labile, undergoing both bond breaking and reforming very rapidly. 
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Figure 1.1. NMR structure of cadmium human metallothionein-2A. Human 
metallothionein is constitute of 61 amino acids: MDPNCSCAAG DSCTCAGSCK 
CKECKCTSCK KSCCSCCPVG  CAKCAQGCIC   KGASDKCSCC  A. The NMR 
studies revealed a two-domain structure with no preferential orientation between the two 
domains. 
 
 
Since their discovery in 1957,
1
  their biological roles/functions have been a 
perplexing topic. The prevailing view is that MT is involved in detoxification of non-
essential metal ions, regulation of essential metal ions, protection from oxidative stress 
and apoptosis, and control of cellular redox status, processing considerable impact on 
human health.
1,5-9
 A number of studies have related deficiencies in MT to metabolic 
disorders such as Wilson's disease and Menkes disease.
10
    MTs are also biologically 
linked to oxidative stress, apoptosis, and control of cellular redox status,
4,11-13
 including 
formation of reactive oxygen species (ROS), which are implicated in the aggregation of 
amyloids,
14-16
 and Vasak et al. suggested that exchange of metal ions between MT and 
aggregated amyloid-β reduces ROS production and Aβ toxicity.14-15,17  A growing body 
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of evidence implicates metal ions and MTs in neurodegenerative diseases, including 
Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS).12,18-20   MT level has 
been shown to increase in many tumors, thus it has been suggested that MT levels may 
serve as useful diagnostics for cancer.
21-22
 In fact, MTs have been found substantially 
unsaturated with metal ions in many tumors.
23
 More recently evidence has been 
presented that shows the existence of metal-unsaturated MTs under physiological 
cellular conditions. These studies suggest that metal-unsaturated MTs are biologically 
significant which actively participate both in cellular metal metabolism and redox 
balance; however, it is unclear whether this is truly apoMT or partially-metalated 
species.
24-27
 Although the underlying mechanism(s) for biochemical processes involving 
MTs are not fully resolved, new insights are beginning to emerge.  For example, 
Petering et al. and Andrews have shown that MTs are reactive toward various oxidants, 
electrophiles and alkylating agents, which potentially diminish deleterious effects of 
these toxic species.
12,28
  Kelly et al. suggested that MTs confer resistance toward 
anticancer therapeutics by alkylation of cysteine residues
29
 and Naganuma et al. showed 
that overexpression of MTs in cancer cells attenuates toxicity of antitumor therapeutics 
and provides intracellular drug sequestration, protecting host tissues from the toxic side 
effects.
30
  
A variety of approaches have been employed to elucidate the metal-binding 
behavior of MT including optical absorption, emission, circular dichroism (CD), and 
nuclear magnetic resonance (NMR) spectroscopies and molecular modeling. Changes in 
the UV-VIS and CD spectra can be related to the identity of the bound metal and the 
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amount of metal loading.
5,31-33
 However, the signals from such experiments represent the 
population-averaged response for all species present in the solution and do not 
distinguish signals from individual species.  NMR and X-ray diffraction studies on 
mammalian MTs revealed a conserved dumbbell-shaped molecule with two distinct 
metal-centered clusters: a -domain (Metal)3(Cys)9 in the N-terminus and a -domain 
(Metal)4(Cys)11 in the C-terminus (see Figure 1.1).
34-37
  Despite the essential atomic 
level structural information for fully metalated MTs provided by such techniques, the 
metalation/demetalation mechanisms remain largely unknown and the structures and 
binding sites for the partially-metalated intermediates are still unclear.  
Recent advances in MS have greatly expanded our capabilities for 
characterization of intact proteins, protein-metal ion complexes and even protein 
complexes.
38-45
  Particularly noteworthy is that ESI is a soft ionization method that 
preserves the non-covalent interactions thereby providing a direct measure of molecular 
distribution of various species present in the solution.
46-51
 These MS approaches that 
afford capabilities to reflect “native” or “native-like” structures has now coined a new 
field termed “native mass spectrometry”.52  In addition to the high resolution and 
accurate mass measurement of analyte(s) by MS, tandem mass spectrometry (MS/MS) 
can be used to elucidate the number and sites of modifications. By combining proteomic 
strategies such as hydrogen/deuterium exchange (HDX),
53
 chemical cross-linking, and 
chemical derivatization now MS has evolved as a powerful technology in structural 
biology that provides information about protein structure, dynamics, composition, and 
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subunit topology and stoichiometry and is complementary to established methods such 
as nuclear magnetic resonance and X-ray crystallography. 
Ion mobility (IM) spectrometry, a gas phase separation of molecules based on 
their differential mobility through a buffer gas, has long been utilized for many 
analytical applications, such as detecting volatile compounds and chemical warfare 
agents.
54
 When coupled with MS, this integrated technique is used to ascertain 
complementary information about the analytes. Furthermore, IM adds an additional 
dimension of separation to MS that provides enhanced analytical peak capacity, which is 
particularly useful for MS-based “-omics” approaches. In fact, IM separates ions in 
milliseconds time scale, which is much faster than most separation techniques.   
More recently, the combination of “native-ESI” with IM-MS has rapidly evolved 
as a stand-alone technique for structural studies that interrogate conformation population 
for individual analyte,
55
  such as elucidation of protein conformations,
56
 construction of 
structural models of protein complexes,
57
 and even characterization of IDPs.
58-65
 
Particularly, ion-neutral collision cross section (CCS) provided by IM-MS reflects 
physical shape and size of the ion.
55
  With further combination with molecular dynamics 
(MD) simulation, this integrated methodology provides candidate structures for the ions 
sampled by IM-MS; for example, the CCS of these analytes can be correlated to 3-D 
shapes and conformations generated by molecular dynamics simulations.
45,66-67
  IM-MS 
has now evolved as a de novo approach to obtain structural information, which is 
extremely valuable for systems that are not assessable by any other traditional methods. 
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Herein we utilized native IM-MS to characterize the metal-binding properties of 
MTs. The major focus of our study deals with fundamental chemistry, i.e., how does 
metal binding affect the chemistry of proteins, specifically we developed the mechanism 
from the stabilities/reactivities and conformations of the reaction intermediates (partially 
metalated species) in metalation/demetalation reactions. Although MTs have been 
widely studied, especially regarding their roles in metal homeostasis, protection against 
cadmium toxicity and neurodegenerative diseases; however, underlying mechanisms 
regarding details of metal-binding intermediates, mechanism of metal accumulation, and 
the role of metal ion in promoting protein conformational changes remain poorly 
understood and a method to directly probe the detailed mechanism was not developed.  
Our studies aim to develop a better understanding of structure-function relationships of 
this biologically important protein.   
In Chapter II, we first demonstrated the utility of native MS in studying metal 
binding properties of MT.  Several studies describing metalation/demetalation have been 
reported; however, the chemistry of intermediate species and site-specific 
metalation/demetalation are still not fully understood, specifically questions regarding (i) 
cooperativity of metal ion binding, (ii) metal ion-depend binding properties, and (iii) 
whether there are preferential binding sites remain hot topics of debate. The major 
complicating factors for studies on metalation/demetalation mechanisms of MT are the 
large number of metal binding intermediates (partially-metalated forms) and the rapid 
rates associated with these processes. Thus, it has not been possible to isolate individual 
components from this complex mixture for structural and mechanistic characterization. 
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MS provides molecular-specific information thus allowing a direct monitor of all species 
without the need of separation, which is ideal for MT systems. In this chapter, we 
showed how MS is used to measure the molecular distribution of starting state, 
intermediates and end-products in metalation/demetalation reactions and to derive the 
metal binding mechanism based on the reactivities of these intermediates.  The model 
protein and metal ion chosen for our method development are human MT-2A and 
cadmium ion as the Cd-MT is one of the very few complexes that have been structurally 
resolved by NMR or X-ray crystallography.
37
  In addition, Cd
2+
 is associated with cancer 
in many human organs, especially lung, kidney, and breast cancers.
68-69
 In fact, recent 
evidence suggests that cadmium causes DNA damage and inactivates DNA repair 
system, potentially leading to cancers or neurodegenerative diseases.
69-71
  It has also 
been proposed that cadmium causes the inactivation of a large number of 
metalloenzymes.
72
 MTs play a major protective role through the uptake of free Cd
2+
 and 
thereby decreasing its adverse effects. The understanding of how MT is involved in 
cadmium detoxification function is of fundamental importance and have the potential for 
providing a more complete picture of cadmium carcinogenesis as well as developing 
new therapeutic strategies.  
We developed a methodology that combines chemical labeling and top-down 
MS/MS approach (named MS-CID-IM-MS) to identify whether there are preferential 
metal-ion binding sites. That is, the metal-ion binding intermediate (partially-metalated 
forms) are chemically derived, m/z-selected and fragmented by a MS spectrometer. We 
studied the reaction intermediates that are derived from either metalation or demetalation 
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reactions. The schematic representation of the analysis procedure is illustrated in Figure 
1.2.  This direct analysis approach identifies the metal binding sites without the need of 
sample purification, which avoids any ambiguity that may arise from long sample 
handling procedures from bottom-up approaches. Specifically, this study shows a new 
strategy to study metal-ion binding sites of a partially-metalated intermediate and 
provides new insights related to metal binding mechanism of MT.  
 
 
 
 
Figure 1.2 Schematic flow diagram of MS-CID-IM-MS approach for studying metal-ion 
binding sites in partially-metalated MT. 
 
 
In Chapter III, ESI-MS is used to monitor metal displacement reaction of MT by 
N-ethylmaleimide (NEM). This competition between NEM and Cd
2+
 provides 
information on the relative stability among the 20 metalation sites; that is, NEM is 
expected to efficiently displace weakly bound Cd
2+ 
ions, but more strongly bound or 
protected metal ions would be displaced more slowly, if at all. This study provides 
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insights into the kinetic stability of the metal ion binding sites. In addition, IM-CID-IM-
MS is employed on a stable partially-alkylated metal-retaining intermediate, revealing a 
weakly binding site in the α domain.  Finally, IM-MS is used to monitor the 
conformation of MT through the metal displacement reaction, providing insights into the 
effects of covalent labeling of free cysteines on its protein conformation. 
In Chapter IV, we employed IM-MS to interrogate conformer population for 
each metalated form of human MT-2A. Specifically, this study provides new insights 
related to the metalation mechanism and conformational changes that occur upon metal 
binding. Since the structure for human fully-metalated Cd7MT-2A was resolved by 
NMR in 1990, further structural studies for apo- and partially-metalated MTs have 
encountered a bottleneck as these metal-unsaturated species are not amenable to 
structure elucidation using NMR spectroscopy, X-ray crystallography, and optical 
methods such as UV/Vis, fluorescence, and circular dichroism. IM-MS provides an 
unparalleled approach to tackle this problem owing to its capabilities of monitoring all 
distinct metalated states by their characteristic m/z ratios by mass spectrometry and 
interrogating conformer conformation for individual metalation state by ion mobility 
spectrometry.  In addition, molecular dynamic (MD) simulations were performed to 
explore candidate conformations that correspond to experimental CCS obtained by IM-
MS. By integrating IM-MS and MD data we are able to construct a metalation pathway 
that shows conformational transition as a function of metal ion bound.  
In Chapter V, we provided a comprehensive investigation of the ion’s effective 
temperature (Teff) that is manipulated by an IM-MS spectrometer. This study focuses on 
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the effects of changes in ion temperature for two structurally diverse proteins, an 
intrinsically disordered protein (apoMT) and a well-structured model protein (ubiquitin). 
Comparisons of experimental CCSs acquired at low Teff and theoretical CCSs generated 
by MD simulation for solution-phase structures provide new insights about 
conformational preferences and retention of solution conformations.    In addition, IM-
MS data for ions that are collisionally activated provides information about folding and 
unfolding landscape (see Figure 1.3). To date, very little is known about the effects of 
metalation on folding/unfolding landscape of metalloproteins. By combining the MD 
simulations as a function of temperature, the change of CCS provides insights into the 
unfolding pathways. 
 
 
 
Figure 1.3 Probing protein folding landscape of an IDP (MT) by IM-MS. 
 
  
 11 
 
 
CHAPTER II  
COMBINING CHEMICAL LABELING, BOTTOM-UP AND TOP-DOWN ION-
MOBILITY MASS SPECTROMETRY TO IDENTIFY METAL-BINDING SITES 
OF PARTIALLY METALATED METALLOTHIONEIN* 
 
Introduction 
Metallothioneins (MTs) represent a family of cysteine-rich, small (~ 6  7 kDa) 
proteins that have been linked to metal homeostasis, including detoxification of non-
essential metal ions and regulation of essential metal ions.
1,5-7,9
 MTs have been isolated 
from a wide range of living systems, including bacteria to human, suggesting that they 
play essential roles in biological systems. Despite intense research since the discovery of 
MT in 1957,
1
 their precise physiological functions have not been fully identified and the 
metalation/demetalation mechanisms remain unclear. 
Metal ion binding by MT has been extensively investigated using a large number 
of techniques.
6,73-78
  UV-VIS and CD spectroscopies have been used to determine the 
identity of the bound metal and the amount of metal loading,
5,33,73,79
 and the kinetics of 
demetalation of Cd7MT has been studied using metal chelators such as EDTA
80-81
 or 
electrophiles such as N-ethylmalimide (NEM).
82
  X-ray diffraction and NMR provide 
atomic level structural information about fully metalated MTs, and these data 
_______________ 
*Reprinted with permission from Chen, S.-H.; Russell, W. K.; and Russell, D. H. 
Combining Chemical Labeling, Bottom-Up and Top-Down Ion-Mobility Mass 
Spectrometry To Identify Metal-Binding Sites of Partially Metalated Metallothionein 
Anal. Chem. 2013, 85, 3229 – 3237. Copyright (2013) by American Chemical Society  
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provide evidence for a conserved dumbbell-shaped molecule that has two distinct metal-
centered clusters, i.e., a Cd3(Cys)9 cluster involving the N-terminus (denoted as the -
domain), and a Cd4(Cys)11 cluster (-domain) involving the C-terminus.
34-37
  It is 
important to note, however, that UV-VIS, CD, and NMR spectroscopies report the 
population-averaged response for all species present in the solution as opposed to 
responses that can be attributed to individual species, thus it is not possible to distinguish 
information related to the intermediate species from that of the final products of the 
reaction.  Likewise, it is not always possible to accurately resolve structural features of 
partially metalated species from XRD data. Consequently, mechanistic details of 
metalation/demetalation remain largely unknown,  as do the structures and binding sites 
for the partially-metalated or supermetalated forms.
83
  
Studies of metal ion-MT interactions are further complicated by the large metal 
ion-binding affinities of the thiolate ligands and the rapid rates of metal accumulation.  
Although a number of partially-metalated MTs have been observed,
47,84
 it has not been 
possible to isolate partially-metalated and metal saturated MTs from a complex mixture 
of MTs.  Apparent binding constants of Cd
2+
 and Zn
2+
 to MT have been reported,
85-87
 
however, comparable information for the partially-metalated intermediates and 
mechanism(s) of metal accumulation have not been resolved owing to a paucity of 
characterization techniques.  On the other hand, MS-based detection can unambiguously 
differentiate signals based on the characteristic m/z for individual metalated species, and 
mass analysis provides direct analysis of individual partially-metalated intermediates and 
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end-products of reactions, including metal uptake, metal exchange, or metal release and 
transfer reactions.
9,88-90
 
Fenselau et al. first demonstrated the application of MS for studies of MTs, 
specifically identification of drug-reactive sites of MTs, metal ion complexation by MT, 
and metal ion transfer from Zn7MT to EDTA and metalloproteins.
46-47,91-95
  Recent 
advances in MS have greatly expanded the capabilities for characterization of intact 
proteins and protein-metal ion complexes.
40,96
  For example, Lobinski et al. combined a 
variety of MS approaches to characterize the MT isoforms from a biological 
cytosol/tissue.
97-98
  Particularly noteworthy is that ESI is a soft ionization method that 
preserves the non-covalent interactions thereby providing a direct measure of molecular 
distribution of various species present in the solution.
46-51
 Consequently, such 
measurements allow for real-time analysis of reaction products without the need for 
isolation/purification of intermediates.  Blindauer et al. have used ESI-MS to 
characterize a kinetically inert metal binding site in bacterial MT SmtA,
99
 and Stillman 
et al. have used similar methodologies to study the binding kinetics of As
3+
 to intact 
MT-1 as well as individual MT-1 domains.
48-49
  More recently, Stillman et al. examined 
MT-1 folding/unfolding accompanying metalation/demetalation processes based on 
changes in the charge-state distribution.
100-101
   
The perception of similar metal ion-MT binding for metals of the same family 
has resulted in Cd-MT being used as a model for Zn-MT; however, differences in ionic 
radii, HSAB (hard-soft acid-base) properties,
102
 and preferred coordination geometries 
between Cd
2+
 and Zn
2+
 may strongly influence the metal binding affinity and metal-
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induced folding of the protein.
9,103-104
 Although both fully-metalated human Cd7MT-2A 
and Zn7MT-2A adopt dumbbell-shaped structures,
105
 it should be noted that Zn-MT and 
Cd-MT show distinct metal binding affinities (Kapp (Cd-MT) ~ 10
16
 M
-1
 and Kapp (Zn-
MT) ~ 10
12
 M
-1
) and the detailed metal binding pathways remain unclear.  Here, ESI-
IM-MS is used to monitor metalation reactions and to measure the abundance of the apo-
protein, partially-metalated intermediates and end products, which provides information 
on the relative reactivities of the intermediates as well as the mechanism of metalation. 
We report the first use of ESI-MS for resolving the relative metal affinities of individual 
partially-metalated MT intermediates. The distinct binding features between Zn-MT and 
Cd-MT and the appearance of preferentially-formed intermediates have motivated us to 
develop a methodology to directly probe metal-binding sites in the partially-metalated 
intermediate. Our results show how combining chemical labeling with both top-down 
and bottom-up proteomic strategies provides direct, site-specific information of 
metalation of the partially metalated intermediates. 
 
Experimental  
Materials 
  Recombinant human metal-free MT-2A (apoMT) and cadmium-saturated MT-
2A (Cd7MT) were obtained from Bestenbalt LLC (Tallinn, Estonia). Cadmium acetate, 
ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate, N-ethylmaleimide 
(NEM), dithiothreitol (DTT), and ammonium acetate were purchased from Sigma-
Aldrich (St. Louis, MO). Sequencing grade modified trypsin was from Promega 
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(Madison, WI). Deionized water (18.2 M) was obtained from a Milli-Q water 
apparatus (Millipore, Billerica, MA). 
Sample preparation 
All apoMT and Cd7MT powder samples were reconstituted in 50 mM 
ammonium acetate (pH 7.4) in a glove box, aliquoted into 10-µL portions, frozen in 
liquid nitrogen and lyophilized. The small portion powder samples were then saturated 
with nitrogen gas and sealed in a glove box so that the proteins were stored within an 
inert environment. The MT samples were stored under nitrogen in -80°C until use. The 
impurities and salts in each aliquot were removed by 6K MWCO spin column (Bio-Rad, 
Hercules, CA), and the sample was then reconstituted by 50 mM ammonium acetate (pH 
7.4) containing 10% methanol and 5 mM DTT before the ESI experiments. The addition 
of 10% methanol in ESI enhances signal-to-noise ratio without affecting complexation 
of metal ion-MTs.
106-107
 Representative mass spectra for apoMT and Cd7MT are shown 
in Figure 2.1.  The concentration of apoMT was estimated by Cd
2+
 titration 
experiments. Owing to the large Cd
2+
 affinity of MT (10
16
 M
-1
), we can assume that the 
free Cd
2+
 is negligible compared to the concentration of Cd
2+
 associated with MT. 
Addition of 50 M Cd2+ to the apoMT solution yields Cd7MT, with respect to a 
concentration of ~ 7 M for the apoMT solution. 
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Figure 2.1. ESI-MS spectra of 7 M solutions of (A) apoMT and (B) Cd7MT. 
Significant amount of signals from impurities and/or degradation products were 
observed in low mass range (m/z < 1200) from the commercial MT samples. A typical 
titration experiment was performed after removing the low molecular weight species by 
a 6K MWCO spin column. 
 
 
Oxidation of apoMT 
Cysteine thiols are very prone to oxidation under aerobic conditions,
33
  including 
formation of disulfide bonds and sulfenic, sulfinic and sulfonic acids. These 
modifications could potentially alter protein 3D structure as well as metal-binding 
affinity. Under our experimental conditions, only disulfide bond modification was 
observed. Therefore, a thiol reductant DTT was added to all solutions of apoMT to 
maintain the cysteinyl thiols in the active reduced states. Figure 2.2 illustrates the effect 
of DTT in preventing apoMT from oxidation.  Protein oxidation can also take place 
during ESI,
108-109
 and to minimize this ESI was performed using the lowest possible 
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capillary voltages (see Figure 2.2).  The mass accuracy (< 20 ppm) and resolution 
(FWHM 18000) of these measurements were sufficient to identify the oxidation state of 
apoMT without ambiguity (see Figure 2.2).  
 
 
 
Figure 2.2.  ESI-MS spectra of a 7 µM apoMT solution in 50 mM ammonium acetate 
with 10% MeOH (pH 7.4) acquired (A) in the absence of DTT at a 1.40 kV capillary 
voltage. The signal for apoMT
5+
 were centered at m/z 1206.2 indicating a shift of 16 Da 
from the theoretical molecular weight (6042.2 Da) and formation of disulfide bonds; (B) 
In the presence of 5 mM DTT at capillary voltage 1.60 kV. The data shows a broader 
isotopic pattern centered around 1207.4 Da, suggesting loss of ~ 10 hydrogens and 
yielding a mixture of apoMT forms with different extent of oxidation. (C) In the 
presence of 5 mM DTT at capillary voltage of 1.40 kV.  The data showed m/z for 
apoMT
5+
 is 1209.2, consistent to the theoretical mass of apoMT with twenty free 
cysteinyl thiols.  The data showed operating a gentle ESI condition by lowering capillary 
voltage to the onset of electrospray (1.40 kV in this case); ESI-induced oxidation was 
significantly eliminated. The results showed the oxidation can be detected by MS and 
reduced by the presence of DTT and using a lowest capillary voltage. 
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Metalation of apoMT and demetalation of Cd7MT 
The metalation experiment was performed by sequential addition of 1, 2, 3 4, 5, 
6, and 7 L of 1 mM of Cd2+ (or Zn2+) to 100 L of a 7 M apoMT solution. Following 
each addition of Cd
2+
, the protein was allowed to react with the metal ion for 1 hr under 
ambient conditions before MS measurement.  Demetalation reactions were performed by 
adding 7 L of 1 mM EDTA or by adding 1.4, 5, 10, 20 L of 10 mM EDTA to 100 L 
of a 7 M Cd7MT solution. The solution was incubated for 1 hr at room temperature and 
then analyzed by ESI-MS.  
Identification of metal-binding sites in Cd4MT partially-metalated intermediates 
The Cd4MT intermediates were obtained by metalation of apoMT (adding 25 M 
of Cd
2+
 to a 7 M apoMT solution) and by demetalation of Cd7MT (adding 700 M 
EDTA to a 7 M Cd7MT solution); and the Cd4MT intermediates were then incubated in 
10 mM NEM in order to react free cysteinyl groups in the partially-metalated species 
and DTT in the solution (1 hr, room temperature). The alkylated metalated products 
were then subjected to direct sequencing by tandem mass spectrometry (top-down 
approach) or in-solution digestion by trypsin at a weight ratio of 1:40 (trypsin to protein) 
for 6 hr (bottom-up approach).  
Mass spectrometry 
All the ESI IM-MS experiments were performed on a Waters Synapt G2 HDMS 
instrument (Manchester, UK), a hybrid quadrupole/ion mobility (IM)/orthogonal time-
of-flight mass spectrometer. MT solution (7 µM) was directly infused into the mass 
spectrometer at a 0.5 µL/min flow rate. A typical ESI spectrum was collected in positive 
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ion mode with a capillary voltage of 1.0  1.6 kV, sample cone voltage of 40  60 V, 
and extraction cone voltage of 4V. The traveling wave ion mobility cell was operated at 
a pressure of 2.98 mbar of nitrogen, with a wave velocity of 300 m/s and a wave height 
of 20 V. All mass spectra were calibrated externally using a solution of sodium iodide.  
Top-down sequence experiments were carried out using “MS-CID-IM-MS” as 
described previously.
110
   Briefly, ion of interest is mass-selected by a quadrupole mass 
spectrometer, and then dissociated using conventional CID conditions. The CID product 
ions are then separated on the basis of size-to-charge ratio by the ‘traveling-wave’ ion 
mobility separator and by m/z by the TOF mass analyzer. The CID experiments were 
performed in trap collision cell with an accelerating voltage of 50  70 V. Descriptions 
of peptide fragment ions are based on the nomenclature system of Roepstorff and 
Biemann.
111-112
 Plotting in a 2-D data display (size-to-charge vs. m/z) yields charge-
specific trendlines.
113
 Trendlines corresponding to species containing metal ions are 
shifted relative to the non-metal containing species. Thus, incorporation of IM adds an 
information-rich dimension to MS-MS, which increases peak capacity and facilitates 
assignment of fragment ions. 
Analysis of apparent binding constant 
The apparent binding constant for individual CdiMT species is defined by 
equation 2.1. Seven sequential metalation reactions are proposed for the binding of Cd
2+
 
to MT: 
Cdi-1MT + Cd
2+  ⇄  CdiMT          Ki =
[CdiMT]
[Cd2+][Cdi-1MT]
          (i = 1  7)            (2.1) 
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where Ki represents the apparent stepwise binding constant of the Cdi-1MT complex, and 
[Cd
2+
] and [CdiMT] refer to the equilibrium concentrations of free Cd
2+
 and CdiMT 
species. As shown in equation 2.2, the relative abundances of Cd
2+
-binding MT 
intermediate species can be used to estimate the relative apparent binding constants, 
which are independent of the initial concentration of apoMT, added Cd
2+
 and [Cd
2+
]free 
in equilibrium condition.
40,96,114
   
  
i+1 i+1 i-1
2
i i
K [Cd MT]/[Cd MT]
=       (2)
K [Cd MT]
       (2.2) 
The titration experiments yielding appreciable amounts of at least three metalated 
species were selected for K ratio analysis. The abundances of different charge states (4+ 
and 5+) were summed to provide a total abundance of CdiMT species. Using equation 
2.2, the Ki ratio can be obtained by the relative abundances of any three adjacent CdiMT 
species. For example, the relative abundances of apoMT, Cd1MT, and Cd2MT can be 
used to calculate K2/K1.  A baseline correction was performed before calculating the 
abundances. Twenty-eight separate titration experiments were analyzed to obtain 
averaged relative apparent binding constants and standard deviations (25 experiments for 
Zn
2+
-MT).  
 
Results and Discussion 
Monitoring partially-metalated intermediates in metalation/demetalation reactions by 
ESI MS 
Metalation of apoMT was studied by using ESI-MS to monitor the abundances of 
the metalated product ions following addition of Cd
2+
 to a solution containing apoMT.  
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Figure 2.3  contains the mass spectra for the region around the 4
+
 charge state as the 
concentration of Cd
2+
 is increased from 0  70 M.  Metalation of apoMT (4+; m/z 
1511.6) yields signals at m/z 1538.5 (Cd1MT
4+
), 1566.3 (Cd2MT
4+
), 1594.4 (Cd3MT
4+
), 
1622.0 (Cd4MT
4+
), 1649.6 (Cd5MT
4+
), 1677.2 (Cd6MT
4+
), to 1704.8 Da (Cd7MT
4+
).  
The ESI-MS data suggest that Cd
2+
 involves sequential addition of Cd
2+
 to CdiMT (i = 0 
– 6); however, the ion abundances suggest that the reactivities of the various species 
differ significantly.  For example, the relative abundance of Cd3MT in the ESI mass 
spectra is quite low suggesting that this species is reactive toward addition of Cd
2+
, 
whereas the high abundance of Cd4MT suggests that this ion is less reactive in terms of 
addition of Cd
2+
. The data suggest the metal-binding affinities of the partially metalated 
species are quite different.   
It should be noted that supermetalated species were not detected in this study, 
even with an excess of Cd
2+
 (70 M Cd2+, 10-fold the concentration of MT, see Figure 
2.3);  non-specific association of the free Cd
2+
 to MT due to the ESI process
40,115
 was not 
observed (see Figure 2.4). The absence of non-specific binding is attributed to the 
presence of DTT in the solution, which binds excess free Cd
2+
 thereby reducing non-
specific Cd
2+
-protein binding during the ESI process.  These results are consistent with 
those reported by Konermann et al. which show that the use of solution-phase weak 
metal chelators sequester metal ions and suppress non-specific protein-metal ion binding 
during the ESI process.
116
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Figure 2.3. ESI-MS spectra of sequential addition of 0  70 M Cd2+ to a 7 M apoMT 
solution. The Cd
2+/
MT mixture was incubated at ambient condition for 1 hr between 
each addition.  Data shown are for the 4+ charge state.  Numbers above peaks denote the 
metal stoichiometry of the CdiMT
4+
 species (i = 0  7). Additional peaks at +23 Da (*) 
and +60 Da (
×
) correspond to sodium and acetate adducts.  
 
 
 23 
 
 
 
Figure 2.4. ESI spectra of addition of 0  7 L of 1 mM Cd2+ solution to a 100 L of 7 
M apoMT solution.  The symbols denote unidentified impurities from the original 
sample (+2: o; +3: ×; +4: Δ; +5: *).  These non-MT species serve as reference proteins 
for indicating non-specific Cd
2+
 association to proteins. The data showed Cd
2+
 only 
binds to MT species as the concentration of Cd
2+
 increases, suggesting that non-specific 
Cd
2+
 association is negligible and the Cd
2+
 binding to MT is specific. 
 24 
 
 
The results for step-wise metalation raise an interesting question: Does 
demetalation occur by a similar mechanism?  This question was addressed by using 
EDTA to remove the metal ions from Cd7MT.  EDTA is expected to efficiently remove 
weakly bound Cd
2+ 
ions, but more strongly bound or protected metal ions should be 
removed more slowly, if at all. Addition of 70 M EDTA to a 7 M Cd7MT solution 
yielded low abundance demetalation products, but as the concentration of EDTA is 
increased (140  500 M), abundant signals for CdiMT (i = 4 – 7) are observed (Figure 
2.5). At EDTA concentrations above 500 M, product ions corresponding to CdiMT (i = 
0 – 4) are observed. Again, Cd4MT appears to be a relatively stable intermediate, and it 
appears that Cd4MT is formed (from apoMT) by step-wise addition of Cd
2+
 to the -
domain and by step-wise depletion of Cd
2+
 from the -domain (from Cd7MT) to yield 
the more stable Cd4MT.  Although both metalation and demetalation appear to be step-
wise, the abundances of the CdiMT (i = 1, 4, and 5) are much higher than that for i = 2, 3 
and 6, suggesting that the reactivities of the individual metalated species differ 
significantly and depend on the degree of metalation. 
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Figure 2.5.  ESI-MS spectra of reactions of 0  2 mM EDTA to a 7 M Cd7MT 
solution. The spectra were taken after 1 hr incubation at ambient condition. Data shown 
are for the 4+ charge state. Numbers above peaks denote the metal stoichiometry of the 
CdiMT
4+
 species (i = 0  7).  The sodium adducts are indicated by asterisks. 
 
 
Analysis of relative apparent binding affinities between individual metal-binding 
intermediates 
Kägi, Vašák and Valle reported an apparent association constant for Cd2+ to MT 
binding ranging from 10
15
  1020 M-1 using a pH dropping experiment and 
spectrophotometric analysis.
85-87
 Rodriguez and Erk used voltammetry to obtain an 
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average affinity constant (ranging from 10
9
  1015 M-1).117-118  These studies were based 
on the assumption that the seven metal ions interact with MT equally, and the difference 
between the metal-binding properties of individual species (intermediates and end-
product) has been neglected and/or is not being detected. However, Maret recently 
reported three pKZn to MT and proposed that MT contains three distinct sites where each 
has different metal-binding affinity.
78
   
Klassen previously showed that mass spectrometry data provide quantitative 
determination of protein-metal ion affinity.
40
 Palacios concluded that ESI signals of 
metal-MT species that differ in their different metalation degree can be related to their 
relative abundances in solution.
119
 Therefore, the various CdiMT species (i = 0  7) are 
assumed to share the same ionization efficiency in our study. The relative abundances of 
CdiMT species (i = 0  7) in the Cd
2+
 titration experiments can be used to estimate 
relative binding constants for the CdiMT intermediates (equation 2.2, see Experimental 
Section for more details).  The ratios of Cd
2+
-binding affinities (see Figure 2.6) for the 
first three metal ions are quite small (K2/K1 = 0.21, K3/K2 = 0.33), whereas the binding 
affinity for the fourth metal is much greater (K4/K3 = 16.1), suggesting that the product 
formed upon binding the fourth metal ion is more stable and/or less reactive toward 
further addition of Cd
2+
. A similar trend is found for K5  K7; the binding affinities 
K5/K4 = 0.20 and K6/K5 = 0.31 are much smaller than that for K7/K6 = 3.94.  These ratios 
can be converted to K1: K2: K3: K4: K5: K6: K7 = 15: 3.0: 1.0: 16: 3.2: 1.0: 3.9 by 
normalizing to K6, suggesting that MT with one, four, and seven metal ions bound are 
more favorable.  The K ratios provide additional data that: (1) Cd
2+
 addition to MT is a 
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two-step process that produces a stable intermediate Cd4MT, and (2) there are two 
independent metalation processes for both steps: (i) Ki/Ki-1 < 1, which means that 
initially the partially metalated species are highly reactive toward Cd
2+
 ions and the 
metal-binding event decreases the affinity of the remaining binding sites, and (ii) Ki/Ki-1 
> 1, which means that there is a sharp increase in the binding affinity for the last metal 
ion, for both steps. This indicates that formation of Cd4MT and Cd7MT are 
thermodynamically favored.    
 
 
 
Figure 2.6. Histograms of relative apparent metal-binding constants for apo- and 
partially-metalated MTs (A) CdiMT and (B) ZniMT (i = 0  6). The K ratios were 
obtained by analysis of relative abundances of (metal)iMT complexes in the metal ion 
titration experiments. See experimental section for more details of data analysis. The 
difference in profiles for CdiMT and ZniMT suggests a metal-dependent binding 
property for human MT-2A.   
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Metal-dependent binding properties  
It is instructive to compare Cd
2+
 and Zn
2+
 binding to MT-2A because the data for 
CdMT-2A differs markedly from that previously reported for other metals and MT-
isoforms.
78,120-122
  There is increasing awareness that the metal-binding properties of one 
isoform can not be directly applied to that of other isoforms;
9,103
 therefore, the properties 
of different metal ions/isoforms must be independently examined.  The metal 
dependence for metalation of human MT-2A was examined by titrating apoMT with 
Zn
2+
 and following the changes in reaction products by ESI-MS; the same set of 
conditions was employed for Zn
2+
 as was used for the apoMT and Cd
2+
 studies. 
Representative spectra are provided in Figure 2.7. The data clearly show that the 
products of metalation ZniMT (i = 0  7) increase as the Zn
2+ 
concentration increases; 
however, unlike what was observed for CdMT, distinct ZniMT intermediates, i.e., i = 4, 
were not observed.   Analysis of the relative apparent metal binding constants for ZniMT 
reveal that all the ratios of K values are < 1 for the binding of the first six Zn
2+
 and 
greater than 1 for the formation of Zn7MT (Figure 2.6). These data underscore the 
significant metal-dependent binding properties of human MT-2A.  Although this 
comparison is limited to the metalation of human MT-2A by Zn
2+
 and Cd
2+
, the results 
provide clear evidence for the need for additional studies for a broader range of metal 
ions and MT isoforms.  
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Figure 2.7.  ESI spectra of a 7 M apoMT solution (100 L) acquired with addition of 0 
 7 L Zn2+ solution (1 mM). The data showed that no distinct ZniMT (i < 7) 
intermediates were formed preferentially. 
 
 
Combining chemical labeling and bottom-up proteomic strategy for identifying metal-
binding sites in partially-metalated MT intermediates 
Preferential formation of the Cd4MT intermediates poses a question: Does 
addition of the four metal ions occur to a single domain ( or ) or are they randomly 
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distributed between both domains? This question is first addressed by using chemical 
labeling (NEM) of free cysteinyl thiols
82,123-125
 followed by bottom-up proteomics 
analysis to determine the NEM labeled sites.  Figure 2.8A contains the MS spectrum 
obtained from an apoMT solution prior to addition of Cd
2+
; the signals at m/z 1209.4 and 
1511.6 correspond to the 5
+
 and 4
+
 charge states of apoMT, respectively.  Following 
addition of 25 M of Cd2+, these signals are shifted to m/z 1297.7 (5+) and to 1621.9 
(4
+
), consistent with formation of Cd4MT (Figure 2.8B).  Addition of NEM yields 
signals at m/z 1523.0 (5
+
) and 1903.0 (4
+
), corresponding to Cd4NEM9MT (Figure 
2.8C).  An aliquot of this solution was then subjected to tryptic digestion for “bottom-
up” characterization (Figure 2.8D).  Peptides labeled P1, P2, P3, P4, P5, and P7 
correspond to metal-free and NEM-labeled tryptic fragment ions; the peptides are 
assigned as C
21
-K
22
, E
23
-K
25
, C
26
-K
30
, C
21
-K
25
, C
26
-K
31
, M
1
-K
20
, respectively. Note that 
these peptide ions all correspond to the cleavage products from the -domain. The 
signals labeled P6 and P8 are assigned as 3
+
 and 2
+
 ions of intact -domain (K32-A61) 
with four Cd
2+
 ions bound; this assignment was confirmed by CID MS (see Figure 2.9). 
The entire sequences and detailed masses of identified fragment ions are listed in Table 
2.1A. It is of interest to note that digestion of Cd4NEM9MT produced peptides from the 
metal-free -domain in < 10 min, whereas the signal for P6 remained unchanged for > 24 
hr, indicating that the four Cd
2+
 ions are tightly bound and/or inaccessible to solvent.  
The data provide convincing evidence that Cd
2+
 ions are preferentially added to the -
domain in agreement with  results reported by Winge and coworkers.
126
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Figure 2.8. ESI mass spectra of (A) a 7 M apoMT solution acquired before titration; 
(B) partially-metalated Cd4MT species obtained by addition of 25 M Cd
2+
 ions to 
above solution at ambient conditions for 1 hr; and (C) reaction product of Cd4MT in 10 
mM NEM. The labeling reaction was carried out at ambient conditions for 1 hr. The 
asterisks (*) denote the impurities present in the apoMT solution; the cross (

) indicates 
Cd7MT; the circles (°) denote Cd6NEM3MT; the triangles (
△
) indicate Cd5NEM5MT. (D) 
ESI spectrum of tryptic digests of the reaction product Cd4NEM9MT obtained in (C). 
The digestion was performed at 37°C at an enzyme: protein ratio 1:40 for 1 hr. The 
identified fragment ions and corresponding sequence are listed in Table 2.1A. The 
sequence of P6 was confirmed by CID MS. 
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Figure 2.9. Top-down sequencing of fragment ion P6. The mass of P6 matches the triply-
charged intact  fragment (residue 31-61) with 4 Cd2+ bound. To confirm the 
assignment, the intact Cd4 fragment was subjected to directly sequencing using top-
down MS-CID-IM-MS approach. The precursor ion P6 was selected by quadrupole and 
then fragmented in trap collision cell. The fragment ions are separated on the basis of 
size-to-charge ratio by ion mobility separator and by m/z by the TOF mass analyzer. The 
2D ion mobility-m/z separation is shown in (A), and the extracted trendlines from the 2D 
plot are shown in (B). The summary of fragment ions identified in shown in (C).  The 
data confirmed the fragment ion P6 is intact Cd4 domain. 
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Table 2.1. Identified fragment ions and sequence coverage of bottom-up (A) and top-
down (B) analysis of Cd4NEM9MT.  
 
 
Direct identification of metal-binding sites of partially-metalated intermediates by top-
down “MS-CID-IM-MS”  
Top-down proteomics strategies, specifically MS-CID-IM-MS,
110
 were also 
employed to sequence the Cd4NEM9MT ion.  This approach minimizes potential 
ambiguity that might arise from metal transfer among binding sites during sample 
preparation and subsequent analysis by the “bottom up” approach.  The MS-CID-IM-MS 
experiment involves m/z selection of the [Cd4NEM9MT]
5+
 ion, followed by CID of the 
m/z selected ion and separation of CID product ions on the basis of ion mobility and m/z.   
Figure 2.10A contains the 2D IM-MS plot of the fragment ion spectra of the 
[Cd4NEM9MT]
5+
 ion. Note that fragment ions that have different charge states fall along 
distinct trendlines, and trendlines for metal ion-containing fragment ions are separated 
MD P N C S C A AG D S C T C AG S C K C K E C K C T S C K K S C C S C C P VG C AK C AQ G C I C K G A S D K C S C C A
b x x x x x x x
y x x x x x x x x x x x x x x x x x x x x x x x x
b x x x x x x x x x x
y x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
61
CID MS
MS-CID-IM-MS
41 51111 21 31
(A)
(B)
No. Sequence Assignment #Cd(II) #NEM Theoretical mass (a/b)* Charge Observed m/z
P1 CK 21-22 0 1 250.121 / 375.170 1+ 375.232
P2 ECK 23-25 0 1 379.165 / 504.212 1+ 504.299
P3 CTSCK 26-30 0 2 541.211 / 791.306 1+ 791.436
P4 CKECK 21-25 0 2 610.269 / 860.364 1+ 860.508
P5 CTSCKK 26-31 0 2 669.306 / 919.401 1+ 919.549
P6 KSCCSCCPVGCAKCAQGCIC KGASDKCSCCA 31-61 4 0 3022.658** / 3461.661** 3+ 1154.741
P7 MDPNCSCAAGDSCTCAGSCK 1-20 0 5 1923.647 / 2548.885 2+ 1275.161
P8 KSCCSCCPVGCAKCAQGCIC KGASDKCSCCA 31-61 4 0 3022.658** / 3461.661** 2+ 1731.609
* theoretical [M+H]
+
 of peptides (a) without and (b) with Cd
2+
- and NEM- bound
** average mass
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from the metal-free trendlines. Extracting mass spectra along each trendline reduces 
spectral congestion and simplifies assignment of product ions, thereby facilitating data 
interpretation (Figure 2.10B).  A series of metal-free, -domain fragment ions ranging 
from b2 to NEM7b25 and y31 to y60 contain 0  9 NEM labels, suggesting that the nine 
cysteines in -domain are fully labeled by NEM. The series of metal containing y ions 
ranging from y5 to y60 provides unequivocal evidence that the four Cd
2+
 ions are located 
in -domain. Figure 2.10C summarizes the identified fragment ions and the model of 
the Cd4NEM9MT species. The results confirm the digestion experiments, i.e., that the 
Cd4 -domain is preferentially formed upon Cd
2+
 coordination to MT.  
These results illustrate the utility of combining chemical labeling and MS-CID-
IM-MS for direct determination of metal binding sites.  Chemical labeling by NEM 
avoids potential ambiguity introduced by metal transfer reactions between binding sites 
and the “top-down” experiments avoid any ambiguity that may arise from (1) low 
abundant tryptic peptides derived from impurities and species other than Cd4NEM9MT 
(see Figure 2.8C), and (2) the recombination of metal ions and digested fragment ions in 
the (“bottom-up”) solution. 
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Figure 2.10.  Top-down sequencing of metalation intermediates Cd4NEM9MT. (A) 2D 
MS-CID-IM-MS spectrum of [Cd4NEM9MT]
5+
. The trendlines are shown for ions of 
different charge states as labeled (+1 to +5). The +1 and +2 fragment ions with metal 
ions bound are indicated as +1M and +2M, respectively. NEM is abbreviated as “N” for 
simplicity. (B) Extracted mass spectra for each trendline. Peaks with an asterisk are for 
ions that shifted by ~ 35 Da from the y fragment ions, corresponding to loss of ammonia 
and water. (C) Summary of identified fragment ions and corresponding model from (B). 
The dotted lines between metal ions and cysteines indicate the metal-thiol coordination 
resolved from NMR studies.  and  indicate the location of the domains.   
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The full characterization of metal-binding sites of the partially-metalated 
intermediates is attributed to the 2D IM-MS separation.  Note that 109 fragment ions 
(see Figure 2.10B) are assignable on the basis of the 2D IM-MS data as opposed to 63 
fragment ions from the 1-D CID MS spectrum (see Figure 2.11).  In addition, identified 
fragment ions from 1-D CID MS spectrum are derived from the protein termini (Table 
2.1B, Figure 2.11), signals derived from residues 15  35 are not assigned, and these are 
essential for identification of all metal ion and NEM-binding sites.  The 2D IM-MS 
provides separation of the overlapping fragment ions, thereby facilitating detection of 
low abundant fragment ions and full characterization of metal-binding sites (Table 2.1B, 
Figure 2.10).  Collectively, the data demonstrate that by combining chemical labeling 
and 2D MS-CID-IM-MS, the intact partially-metalated intermediates can be trapped 
directly and binding sites can be fully characterized without any further sample 
treatments.  
Top-down sequencing was also employed to characterize the demetalation 
intermediate Cd4MT.  Briefly, the Cd4MT intermediate was obtained by adding 100 
equivalents of EDTA to a solution of Cd7MT; after 1-hr, NEM was added to the solution 
to form Cd4NEM9MT (see Figure 2.12).  The 2D IM-MS data for Cd4NEM9MT 
generated by demetalation clearly show that the four Cd
2+
 ions that reside in the -
domain are retained, whereas the Cd
2+
 ions in the -domain are removed (by EDTA) and 
the free binding sites are all labeled by NEM (Figure 2.13).  The experiment provides 
further evidence that the binding of Cd
2+
 to human MT involves a two-step domain-
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specific mechanism, i.e. metal ions are first added to the -domain followed by addition 
to the -domain, metal ions are removed in the reverse order. 
 
 
 
Figure 2.11. Regular CID MS spectra of [Cd4NEM9MT]
5+
. A total of 63 fragment ions 
are identified. The sequence coverage is shown in Table 2.1.  
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Figure 2.12. ESI spectra of a 7 M solution of (A) Cd7MT acquired before any 
treatments, and sequential addition of (B) 700 M EDTA and (C) NEM (final 
concentration 10 mM). A stable partially-metalated Cd4MT species was obtained after 1 
h reaction of Cd7MT and EDTA, and reaction of Cd4MT and NEM yields Cd4NEM9MT. 
The reaction product Cd4NEM9MT was then subjected to directly sequencing by MS-
CID-IM-MS approach.  
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Figure 2.13. Analysis of metal-binding sites of partially-metalated Cd4MT intermediate 
obtained from the metal ion removal of Cd7MT by EDTA. The product Cd4NEM9MT 
was then subjected to MS-CID-IM-MS analysis.  (A) 2D IM-MS plot of fragment ions, 
(B) extracted mass spectra for each trendlines, (C) summary of identified fragments and 
corresponding model. The data demonstrates the four Cd
2+
 located in domain are 
strongly bound and retained in the demetalation process.  
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Conclusion  
ESI-IM-MS is used to probe the relative metal-binding affinities between 
individual partially-metalated metallothioneins, and direct identification of metal-
binding sites in partially-metalated intermediates is probed by combining chemical 
labeling (NEM) of cysteine side chains with bottom-up and top-down proteomics 
techniques.   The relative apparent binding constants reveal distinct binding pathways for 
human ZniMT-2A and CdiMT-2A (i =0  7). The discovery of a stable intermediate, 
Cd4MT, indicates that Cd
2+
 binds MT through a two-step process; conversely, Zn
2+
 
reacting with apoMT does not yield similar ZniMT intermediates.  The Cd4MT 
intermediate was characterized by using chemical labeling and 2D IM-MS top-down 
approach, providing site-specific information for the metal-binding sites of intact 
partially-metalated MT. These results provide direct evidence that Cd
2+
 binding to 
human MT-2A occurs by a two-step mechanism that is domain specific: the Cd4-
domain is preferentially formed followed by filling of the -domain, and demetalation 
(by EDTA) occurs by reversing this sequence.  The data also indicate the Cd4-domain 
is more thermodynamically and kinetically stable relative to the Cd3-domain. These 
results highlight the advantage of MS-based approaches for studies of binding 
mechanism of proteins involving multiple metal ions.  The MS data for reaction 
intermediates and final products can be distinguished and specific metalated forms can 
be directly selected and characterized for the binding sites without the need of sample 
purification.  This study provides essential guidance for future investigations employing 
IM-MS to gain insights into the correlation between reactivities and 3-D structures of the 
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various partially-metalated species and structural transitions between the Zn
2+
 and Cd
2+
-
induced folding.  
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CHAPTER III  
PROBING KINETIC STABILITIES OF METAL ION-BINDING SITES IN 
HUMAN CD7METALLOTHIONEIN BY N-ETHYLMALEIMIDE: EVIDENCE 
FOR A WEAKLY COORDINATED SITE IN THE ALPHA DOMAIN 
 
Introduction 
Metallothioneins (MTs) constitute a family of low molecular weight proteins 
with a high cysteine content and are known for their ability to interact a wide variety of 
metal ions. Mammalian MTs are known to bind seven divalent (Cd
2+
 or Zn
2+
) ions or 
twelve monovalent (Cu
+
) ions in two metal-sulfur clusters.  MTs are proposed to play a 
role in detoxification of heavy metal ions and regulation of essential metal ions.  In 
addition to metal ions, MTs are also reactive toward oxidants, electrophiles and 
alkylating agents such as iodoacetamide and N-ethylmaleimide (NEM). It has been 
proposed that MTs confer resistance toward anticancer therapeutics by alkylation of 
cysteine residues and the overexpression of MTs in cancer cells attenuates toxicity of 
antitumor therapeutics and provides intracellular drug sequestration. These results 
indicate that MT might react with a variety of biologically active electrophiles and 
thereby alter their cellular effects.
82
  Results from these studies suggest that the active 
form(s) of MT in vivo is probably not the well-known fully-metalated structure 
described by X-ray crystallography or NMR spectroscopy and that the thiol chemistry is 
the central of MT’s mechanism of action.75  
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Fluorimetric methods have been developed to glean information on mechanistic 
insights into metalation/demetalation/metal-displacement reactions of MTs. Results from 
these studies suggest that the metal ions (Zn
2+
 and Cd
2+
) are thermodynamically stable 
but kinetically unstable, and the metal ions in the β domain are more dynamic than those 
in the α domain. These real-time kinetic studies usually rely on external metal-ion 
reactive fluorescent reporters, thus the information obtained are limited to the amount of 
metal ions bound/released. Consequently, the information about distribution of reaction 
intermediates is largely unknown. On the other hand, using state-of-the-art MS-based 
techniques it is possible to resolve signals from individual conformers in the solution and 
to provide direct information on the reaction intermediates.  
Here we report detailed kinetic profiles for each of the metal-displaced 
intermediates of MT in the reaction with a model alkylating agent N-ethylmaleimide 
(NEM). NEM has been long used to quantify the free cysteine residues in MTs through 
the formation of covalent thioether bonds.
85
  In our study, NEM is used to probe the 
dynamic metal ions.  The molecular-specific kinetics provides direct information on the 
mechanism of displacement reaction and evidence for the cooperative binding of the two 
domains. Furthermore, we have previously showed the utility of MS-CID-IM-MS has 
been previously shown for structural characterization of short-lived partially-metalated 
intermediates. Here, a stable partially-alkylated metal-retaining intermediate was 
isolated and directly sequenced by mass spectrometer, providing direct information on 
the metal ion- and NEM binding sites. Our data reveals a weakly coordinated site in the 
α domain.  
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Experimental  
Sample preparation 
Cadmium-saturated MT-2A (Cd7MT) powder sample (Bestenbalt LLC, Tallinn, 
Estonia) was reconstituted to 10 M in 50 mM ammonium acetate (pH 7.4) containing 
10% methanol and 5 mM DTT (Sigma-Aldrich, St. Louis, MO).  Metal displacement 
reaction was performed by adding 1, 20, 40, 80, 320, and 2000 molar equivalents of 
NEM to a 10 M Cd7MT solution. The solution was incubated for 1 h at room 
temperature and then analyzed by ESI-MS. The kinetic study of metal displacement was 
carried out by adding 200 equiv NEM to a 10 M Cd7MT solution. Aliquots were taken 
at various intervals from the time of mixing and the reaction was monitored continuously 
by ESI-MS for 24 h at room temperature. 
To identify the metal-ion binding sites in a partially-metalated intermediate, the 
alkylated partially-metalated intermediate is m/z selected and then subjected to direct 
top-down sequencing viz. a stable reaction intermediate Cd4NEM10MT yielded after 1 h-
reaction of Cd7MT and 200 equiv NEM is subjected to top-down tandem mass 
spectrometry (MS-CID-IM-MS-approach) as described previously.
127
   
Ion mobility-mass spectrometry 
All mass spectra and drift time were collected using a Waters Synapt G2 HDMS 
instrument (Manchester, UK). 10 µM sample solution was directly infused into the mass 
spectrometer at a 0.5 µL/min flow rate. ESI spectra was collected in positive ion mode 
with a capillary voltage of 1.0  1.5 kV using a sample cone voltage of 10 V and 
extraction cone voltage of 1 V. All mass spectra were calibrated externally using a 
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solution of sodium iodide.  He and N2 ratio in the traveling wave ion mobility cell was 
optimized toward a lower effective ion temperature.  A TW wave velocity of 550 m/s 
and a wave height of 25 V were used. Cytochrome c, myoglobin and ubiquitin were used 
to calibrate collision cross section (CCS) as described previously.
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Kinetic analysis 
Relative abundances were determined by performing a baseline correction and 
calculating the area under the peaks. The abundance of species with the same number of 
metal ions bound (i = 0  7) in different charge states were summed together to provide a 
total abundance of CdiMT species. The kinetic data were analyzed using Mathematica 
(Wolfram Research Inc., Champaign, IL). Seven consecutive, irreversible reactions were 
proposed to account for the reaction of Cd7MT and 200 equiv NEM (equation 3.1, see 
below for the detailed rate low). The seven rate constants were empirically determined to 
obtain best fit of the experimental data. 
 
   (3.1) 
7 6 5 4 3 2 1
7 6 5 4 3 2 1 0  
k k k k k k k
Cd Cd Cd Cd Cd Cd Cd  Cd    (3)
NEM NEM NEM NEM NEM NEM NEM
      
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MD simulations 
MD simulations were performed using AMBER 9.0. FF99SB force field.
129
 The 
NMR structures of separate domains (1MHU, 2MHU)
37
 of human MT-2A was 
connected as starting structure for fully-metalated Cd7MT. The simulation and 
parameters for Cd
2+
 ion follows the procedure described previously.
65
  Topology and 
partial charge of NEM-labelled cysteine will be generated using RESP ESP charge 
Derive program (RED).
130
  The structures of Cd4NEM10MT and NEM20MT were 
energy-minimized, following by simulations at 300 K in vacuo or implicit solvent model 
to generate gas phase- and solution phase structures. Dehydrated structures were 
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obtained by in vacuo minimization of solution phase structures for 10,000 steps as 
described previously.
65
  CCS calculations were carried out using trajectory method.
131
 
 
Results and Discussion 
Metal displacement of Cd7MT by NEM 
Displacement of Cd
2+
 ions from Cd7MT was studied by sequentially adding an 
alkylation agent NEM in to a Cd7MT solution (Figure 3.1).  Addition of small amounts 
of NEM (< 40 equiv) does not lead to significant amounts of Cd
2+
 displacement. We 
note that the 7 Cd
2+
 ions can be still bound even the protein is labelled by a few number 
of NEM eg. Cd7NEM3MT at 20 equiv NEM (Figure 3.1). Increasing the concentration 
of NEM yielded more extensive NEM labeling and metal-release. After 40 equiv NEM, 
product ions corresponding to four Cd
2+
-bound metalated intermediates (Cd4 species) are 
observed. Above 80 equiv NEM, Cd4NEM10MT intermediate is the most abundant 
product.  In solutions having high molar excess of NEM (2000:1 to Cd7MT), the 
Cd4NEM10MT remains as the dominant species and the metal-stripped MT containing 20 
NEMs are detected at lower abundance.  
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Figure 3.1. ESI-MS spectra of a solution of Cd7MT to which 1  2000 equiv NEM were 
added. Cd4NEM10MT was observed as the most stable intermediate during the entire 
titration. Data shown limited to 5+ region. 
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A weakly coordinated metal ion binding site in the α domain 
The most stable intermediate, [Cd4NEM10MT]
5+
, was analyzed by MS-CID-IMS-
MS
127
 to identify the locations of metal ions in the Cd4 species (Figure 3.2). A series of 
-domain fragments including b ions from b2 to NEM7b25 and y ions from y31 to y60 with 
09 NEM bound suggest that the nine cysteines in -domain are fully labeled by NEM. 
The presence of a series of Cd
2+
 ion containing y ions from y5 to y60 also provides 
evidence that the four Cd
2+
 ions are located in -domain. The data show that the four 
Cd
2+
 ions located in the -domain are tightly bound, whereas the three Cd2+ ions bound 
to the -domain are replaced upon addition of nine NEMs. In addition, the presence of 
fragment ions Cd4y28 and Cd4NEM1y29 are consistent with alkylation to cys
33
 in the -
domain. This result suggests that the NEM reaction is consistent with the two-step 
domain-specific displacement mechanism, i.e. the four Cd
2+
 ions resided in the -
domain are strongly bound even in the presence of a large excess of chelator or 
electrophile.  
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Figure 3.2. MS-CID-IM-MS analysis of the demetalation intermediate 
[Cd4NEM10MT]
5+
. (A) 2D IM-MS plot of fragment ions, (B) extracted mass spectra for 
each trendlines, (C) summary of identified fragments and corresponding model. This 
result demonstrates the four Cd
2+
 located in domain are strongly bound and retained in 
the displacement reaction by NEM.  
  
 51 
 
 
Displacement kinetics 
Kinetic stabilities of the individual partially-metalated intermediates were 
examined by monitoring individual signals as a function of time with NEM 
concentration held constant (200: 1 to Cd7MT) (see MS spectra in Figure 3.3).  The 
removal of Cd
2+
 from Cd7MT over 24 h appears to be a two component reaction; rapid 
loss of three metal ions followed by slow loss of the remaining four metal ions. The Cd4 
species was observed as the least reactive intermediate during the entire displacement 
process.  The reaction was assumed to occur through sequential displacement from 
Cd7MT with seven individual displacement rates (see Experimental section). 
Under the condition of large excess of NEM, the reaction is assumed to follow 
first-order kinetics. The reactions are also irreversible because the resulting thioether C-
S bonds are covalent. Figure 3.4 contains kinetic plots for individual intermediates and 
end-product. The kinetic data for Cd7 species follows an exponential decay, whereas the 
Cd6  Cd1 species show an initial rise followed by an exponential decay to the final Cd0 
products. The equivalents of Cd
2+
 ions retained by MT over time can be calculated from 
the abundance of CdiMT species present in the solution (see Figure 3.4I). A 
biexponential decay is observed with a cross point at 1.4 which corresponds to 4.3 equiv 
Cd
2+
.  The NEM labeling and subsequent release of three metal ions was initially fast 
(kCd
2+
, fast: 8.4  10
-3
 min
-1
, < 50 min), and the latter reaction to remove the last four 
metal ions required > 24 h (kCd
2+
, slow: 4.8  10
-4
 min
-1
).  
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Figure 3.3. Reaction of Cd7MT and 200 equivalents of NEM. The reaction was 
continuously monitored by ESI-MS over 24 hr. Signal of CdiMT with different number 
of NEM bound (x; 0-20) are combined to provide a total abundance of a Cdi species. 
Kinetic curve and fitting of individual Cdi species was shown in Figure 3.4. 
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Figure 3.4. Kinetic plots for individual Cdi species. 200 molar equiv of NEM was added 
to Cd7MT and the reaction was continuously monitored by ESI-MS over 24 h. The ion 
signals for each Cdi species containing different numbers of NEM (x), CdiNEMx, are 
summed together to provide a total abundance of Cdi species.  The data points show the 
relative abundance for the Cdi species and dashed lines are fitting curves. The rate 
constants are obtained by fitting equations of seven consecutive reactions. 
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The fitting of individual intermediates revealed a two-step displacement pattern 
and four classes of reaction rates that differ by greater than 3 orders of magnitude: (i) 10
-
4
 min
-1
: k4; (ii) 10
-3
 min
-1
: k3; (iii) 10
-2
 min
-1
: k2 , k1 , k6 , k7; (iv) 10
-1
 min
-1
: k5. For 
displacement of the metal ions in the β domain (Cd7  Cd4), the rates of dissociation of 
the first and second metal ions (k7 and k6) are moderate (10
-2
 min
-1
), while the third 
metal ion is lost much faster (16 times; k5: 0.92 min
-1
; Figure 3.4C). A similar kinetic 
pattern was observed for the displacement of metal ions in the α domain (Cd4  Cd0). 
The metal displacement of Cd4 species was very slow (k4: 4.8 10
-4
 min
-1
; Figure 3.4D), 
while the rates of loss of the remaining three Cd
2+
 were much faster (14 times for the 
fifth metal ion, k3: 0.0068 min
-1
, Figure 3.4E; 41 times for the sixth metal ion, k2: 0.020 
min
-1
, Figure 3.4F; and 115 times for the seventh metal ion, k1: 0.055 min
-1
, Figure 
3.4G).  
The kinetic plots for the individual species reveal distinct stabilities of these 
intermediates that differ by > 3 orders of magnitude: stability order: Cd4 >> Cd3 > Cd2 > 
Cd1 ~ Cd6 > Cd7 > Cd5. We concluded this data as follows: (i) the overall dissociation 
rate of metal ions from the -domain (k4k1) are much slower than that in the -domain 
(k7k5), indicating stronger metal-thiolate coordination and greater kinetic stability of 
the -domain, consistent with previous results;37 (ii) the well-known two-step kinetic 
profile of metal removal rate
81-82,132
 of MT is attributed to the rate-determining steps for 
the -domain (Cd4 = 0.00048 min
-1
) and -domain (Cd6 = 0.056 min
-1
); however, the 
slight difference between k7 (0.090 min
-1
) and k6 (0.056 min
-1
) are difficult to probe by 
other methods; (iii) the release of first metal k7 is faster than k6, suggesting that there is a 
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weakly bound metal in the -domain, which is consistent with a previous report;133 (iv) 
the existence of a weak metal binding site in the -domain was also indicated by the 
alkylation on Cys
33
 in the presence of a large excess of NEM (Figure 3.2). In addition, 
this NEM labeling on Cys
33
 suggests that the binding strength of the four cysteinyl 
ligands to a single Cd
2+
 is not equal. The relatively high stability of Cd4NEM10MT 
implies that the alkylation on Cys
33
 does not lead to cooperative collapse of the -
domain, which suggests less contribution of the Cys
33–Cd2+ coordination in the overall 
stability of the -domain.  
Cooperativity  
Vasak, Petering, Winge and Hunziker have suggested that Cd
2+
 binding to MT is 
cooperative.
81,107,126,134
 The evidence is the observation of preferential formation of an 
intermediate associated with both metalation/demetalation processes, viz. Cd4MT.  More 
recently, however, Stillman and coworkers proposed non-cooperative binding based on 
the observation of a sequential, independent metal binding manner in the metalation 
process.
120
 Thus, whether the metalation/demetalation process is cooperative or non-
cooperative remains controversial.  The kinetic plots contained in Figure 3.4 suggest of 
Cdi species in the metal-displacement experiment follow a cooperative loss of the metal 
ions for each of the domains: the rates of dissociation for the -domain: Cd7 ~ Cd6 < 
Cd5; -domain: Cd4 < Cd3 < Cd2 < Cd1. These results suggest the binding mechanism 
for each of the domains is cooperative rather than independent. The preferential retention 
of metal ions in the -domain also suggests a greater kinetic stability.  
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Effect of NEM labeling on conformation 
The data contained in Figure 3.2 suggests the Cys
33
 is a weak metal binding site 
in the -domain. Fenselau et al. has shown that Cys33 is one of the solvent-exposed sites 
and is selectively targeted by anti-cancer reagents,
93-94
 presumably the Cys
33
 is the 
terminal ligand in the -domain.93 Huang et al. have also demonstrated that the mutant 
of Cys
33
 of monkey MT1 does not disrupt the structure of Cd4Cys11 -domain; 
presumably the Cys
33
 is the terminal ligand in the -domain.135  
To probe the role of Cys
33
 and the effect of convent binding on conformation 
further, IM-MS is used to follow the metal-displacement reaction by NEM.  The CCS 
profiles contained in Figure 3.5 suggested Cd4NEM9MT exhibits similar conformation 
to Cd4NEM10MT, indicating that the additional NEM label on Cys
33
 does not disturb 
overall molecular shape, in line with the previous study.
135
  However, it is somehow 
surprised that the compact conformation is retained through the metal displacement 
reaction viz. the NEM-labelled species including reaction intermediates (Cd4NEM9MT 
and Cd4NEM10MT) and final product (NEM20MT) are composed of a single ordered ion 
population (right panel, Figure 3.5). In contrast, the demetalation of Cd7MT by EDTA 
results in a significant conformational change that is from order-to-disorder and 
compact-to-extended; that is, the fully metalated Cd7MT is composed of an ion 
population that is ordered and compact while the conformational diversity/flexibility is 
much greater when the metal ions are removed (left panel, Figure 3.5).  
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Figure 3.5. Ion mobility data for the fully-metalated Cd7MT and the reaction 
intermediates and products in demetalation and metal displacement reactions. The data 
show distinct conformational transitions where metal displacement yields compact, order 
conformations while metal removal induces a disordered conformational population 
ranging from extended to compact conformers.  
 
 
The data described above clearly show that the demetalation and metal 
displacement reactions yield products that are very different in terms of the structural 
populations, even when the number of metal ions bound is identical. The contrast 
between the two reactions raises an interesting question: how does NEM maintain the 
compact conformation of MT?  That is, the removal of metal ions and metal-thiolate 
interaction can lead to protein unfolding but the intramolecular interaction between the 
protein segments appear to be retained by the addition of NEM.  To understand the 
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conformation preference and intramolecular interaction of the reaction products, MD 
simulations were performed to generate gas phase-, solution-, and dehydrated 
structures.
65
 
The MD data contained in Figure 3.6 assume a stable conformation for Cd7MT 
over the 20ns time window whereas that of the demetalated products Cd4MT and apoMT 
fluctuate significantly between open and close states, suggesting that the removal of 
metal-thiolate interaction results in an ion population that is largely disordered, 
consistent to our ion mobility results (Figure 3.5) and solution studies.
9
 On the other 
hand, the simulation data suggest a narrow conformational population for the metal 
displaced products Cd4NEM10MT and NEM20MT, suggesting that intramolecular 
interaction are retained after the replacement of metal ion by NEM.  To identify the type 
of interaction that holds the structures of the NEM-labelled proteins compact, the MD 
trajectories were further analyzed. Table 3.1 summarizes the results of hydrogen bond 
analysis of these four reaction products that shows the NEM-labelled CdiMTs contain a 
greater number of hydrogen bond compared to that of CdiMT. In addition, the frequency 
of hydrogen bond, which provides information for the bond stability, is also higher for 
the NEM-labelled CdiMTs.  The data suggest the 3-D conformation of the NEM-
displaced CdiMTs is partly locked into place by hydrogen bonds that are introduced by 
NEMs. 
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Figure 3.6. MD simulations and representative conformations of dehydrated Cd7MT and 
the demtallation products Cd4MT and apoMT (top panel) and metal displacement 
products Cd4NEM10MT and NEM20MT. The data suggest the conformations of apoMT 
and Cd4MT vary significantly in time (disordered conformation) whereas the 
conformations of Cd7MT, Cd4NEM10MT, and NEM20MT are relatively stable and adopt 
globular–like conformation (ordered conformation).  
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Table 3.1. Hydrogen bond analysis for simulated solution structures of the demetalation 
(Cd4MT and apoMT) and metal-displaced (Cd4NEM10MT and NEM20MT) products over 
a 20-ns MD simulation time window.  The data suggest metal-displaced products exhibit 
greater number of hydrogen bonds than that of demetalated products.   
 
atom# :res@atom atom# :res@atom atom# :res@atom
| 119 :10@O | 165 :14@HG1 164 :14@OG1 | 18.97 2.969
| 287 :23@O | 354 :28@HG 353 :28@OG | 11.77 3.179
| 770 :61@O | 549 :43@HZ2 547 :43@NZ | 18.79 3.017
| 770 :61@O | 550 :43@HZ3 547 :43@NZ | 18.54 3.006
| 770 :61@O | 548 :43@HZ1 547 :43@NZ | 18.04 3.013
| 771 :61@OXT | 549 :43@HZ2 547 :43@NZ | 15.67 3.049
| 771 :61@OXT | 550 :43@HZ3 547 :43@NZ | 14.97 3.074
| 771 :61@OXT | 548 :43@HZ1 547 :43@NZ | 14.78 3.059
| 285 :23@OE2 | 237 :20@HZ3 234 :20@NZ | 12.18 2.964
| 284 :23@OE1 | 237 :20@HZ3 234 :20@NZ | 11.37 2.994
| 285 :23@OE2 | 236 :20@HZ2 234 :20@NZ | 10.67 2.97
| 694 :55@OD1 | 717 :56@HZ3 714 :56@NZ | 10.43 3.017
| 368 :22@O | 471 :27@HG1 470 :27@OG1 | 42.35 3.316
| 97 :6@O | 213 :14@HG1 212 :14@OG1 | 39.85 3.369
| 151 :10@O | 213 :14@HG1 212 :14@OG1 | 30.8 3.503
| 346 :21@O | 471 :27@HG1 470 :27@OG1 | 30.45 3.165
| 201 :13@O | 213 :14@HG1 212 :14@OG1 | 28.25 3.321
| 1101 :61@O | 997 :56@HZ3 994 :56@NZ | 21.2 3.009
| 685 :37@O | 564 :32@HG 563 :32@OG | 20.25 3.296
| 31 :2@O | 57 :4@HD22 55 :4@ND2 | 18.9 3.043
| 1102 :61@OXT | 995 :56@HZ1 994 :56@NZ | 18.55 3.018
| 1102 :61@OXT | 997 :56@HZ3 994 :56@NZ | 18.4 3.057
| 1101 :61@O | 995 :56@HZ1 994 :56@NZ | 17.9 3.06
| 1101 :61@O | 996 :56@HZ2 994 :56@NZ | 17.3 2.995
| 1102 :61@OXT | 996 :56@HZ2 994 :56@NZ | 14.25 3.03
| 1101 :61@O | 56 :4@HD21 55 :4@ND2 | 10.1 3.12
| 368 :22@O | 95 :6@HG 94 :6@OG | 73.9 3.113
| 634 :37@O | 564 :32@HG 563 :32@OG | 41.3 3.378
| 29 :2@OD2 | 57 :4@HD22 55 :4@ND2 | 33 3
| 380 :23@OE1 | 213 :14@HG1 212 :14@OG1 | 30.8 3.107
| 648 :38@O | 564 :32@HG 563 :32@OG | 29.15 3.125
| 381 :23@OE2 | 213 :14@HG1 212 :14@OG1 | 27.35 3.166
| 28 :2@OD1 | 57 :4@HD22 55 :4@ND2 | 26.05 3.104
| 932 :61@OXT | 711 :43@HZ3 708 :43@NZ | 21.1 3.003
| 932 :61@OXT | 710 :43@HZ2 708 :43@NZ | 20.9 3.021
| 932 :61@OXT | 709 :43@HZ1 708 :43@NZ | 20.85 2.981
| 931 :61@O | 710 :43@HZ2 708 :43@NZ | 20.4 3.011
| 931 :61@O | 709 :43@HZ1 708 :43@NZ | 19.65 3.02
| 931 :61@O | 711 :43@HZ3 708 :43@NZ | 18.4 3.039
| 45 :3@O | 429 :25@HZ2 427 :25@NZ | 16.55 3.096
| 496 :29@OD | 56 :4@HD21 55 :4@ND2 | 16.1 3.104
| 45 :3@O | 430 :25@HZ3 427 :25@NZ | 16 3.11
| 45 :3@O | 428 :25@HZ1 427 :25@NZ | 14.65 3.089
| 259 :17@O | 747 :46@HE21 746 :46@NE2 | 10.05 3.164
Cd4NEM10MT
%occupied distance (Å)
DONOR ACCEPTOR:H ACCEPTOR
apoMT
Cd4MT
NEM20MT
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Conclusion  
The mechanism of metal-displacement of cadmium binding human 
metallothionein-2A (Cd7MT) is investigated by electrospray ionization ion mobility 
mass spectrometry and molecular dynamics simulations. Metal-displacement reveals 
distinct kinetic stabilities of the various intermediates that differ by > 3 orders of 
magnitude in kinetic rate constants. Directly sequencing of a kinetic intermediate 
[Cd4NEM10MT]
5+
 by “MS-CID-IM-MS” suggest that the metal-displacement occurs in 
the β domain before the α domain, a reverse direction to the metalation,127 suggesting a 
greater kinetic stability for the α-domain. The two-step metal-displacement kinetic 
profile suggests a cooperative binding of three Cd
2+ 
ions in the β-domain followed by the 
remaining four Cd
2+
 ions in the α-domain. The MS-CID-IM-MS data also suggests that 
Cys
33
 is a weak binding site in the α domain, and labeling of Cys33 does not lead to 
collapse of the metal-thiolate cluster. On the other hand, IM-MS data show distinct 
conformational changes between metal removal and metal displacement reactions: metal 
removal by EDTA induces a disordered conformation population ranging from compact 
to extended conformation whereas the metal-displacement by NEM yields globular-like 
compact conformation.  We interpreted this data as an evidence of lose of its disordered 
characteristics and formation of ordered and globular-like conformations.  Independent 
MD simulations on the demetalated and metal-displaced products show distinct reaction 
pathways, consistent to our IM-MS results. A disordered conformational population was 
observed after metal ions are removed but metal displacement by NEM yields a compact 
conformation due to formation of hydrogen bonds.  
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CHAPTER IV  
METAL-INDUCED CONFORMATIONAL CHANGES OF HUMAN 
METALLOTHIONEIN: A COMBINED THEORETICAL AND 
EXPERIMENTAL STUDY OF METAL-FREE AND PARTIALLY-METALATED 
INTERMEDIATES 
 
Introduction 
One-third of proteins naturally bind metal ions in order to provide activity and/or 
stability.
136
 Aberrant metalation has been linked to protein misfolding and human 
disease, specifically pathogenic processes of amyloidosis, including A-peptide 
aggregation in Alzeheimer’s diseases (AD), -synuclein in Parkinson’s disease (PD), 
and prion protein in transmissible spongiform encephalopathies (TSE).
137
  There is 
increasing evidence that Cu
2+
 ions disrupt A-peptide from adapting a -sheet 
conformation,
138-139
 and Cu
2+
 and Fe
3+
 ions trigger structural transformation as well as 
increase in fibrillation rate of -synuclein.140  Similarly, Zn2+ and Cu2+ ions alter prion 
protein aggregation pathways and formation of amorphous aggregates instead of 
fibrils.
141
  Not surprisingly, however, metal-protein interactions also have potential as 
 
 
_______________ 
 
*Reprinted with permission from Chen, S.-H.; Chen, L.; and Russell, D. H. Metal-
Induced Conformational Changes of Human Metallothionein-2A: A Combined 
Theoretical and Experimental Study of Metal-Free and Partially Metalated Intermediates 
J. Am. Chem. Soc. 2014, 136, 9499 – 9508. Copyright (2014) by American Chemical 
Society  
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therapeutic agents.  For example, Mg
2+
 inhibits -synuclein aggregation,142 and binding 
of Zn
2+
 to A-peptide reduces cytotoxicity.143   Metallothioneins (MTs), a class of 
metalloproteins, are known as one of the most important in vivo metal reservoirs and 
transporters.
1,144
  MTs are cysteine-rich and possess diverse metal binding preferences 
that serve to regulate essential metal ions and as protection against toxicity of non-
essential metal ions.
8-9
  It is becoming increasingly evident that MTs play protective 
roles in neurodegenerative diseases by buffering free zinc in amyotrophic lateral 
sclerosis (ALS)
145
 and reducing copper toxicity and production of reactive oxygen 
species (ROS) in AD.
14-15
  MTs are also free-radical scavengers and protect against 
nephrotoxicity from Cd
2+
 exposure.
8,146
 In addition, MTs have been found substantially 
unsaturated with metal ions in many tumors,
23
 and recent evidence suggests that the 
metal-unsaturated MTs are biologically active in terms of cellular metal metabolism and 
redox balance.
24-25
 Despite the roles of MTs in various diseases, underlying mechanisms 
regarding the role of metal ions in promoting protein conformational changes as well as 
influencing subsequent chemical/biological pathways are poorly understood.   
It is generally accepted that structures of MTs are determined by the number and 
type of metal ions they coordinate.
9
  Structure determination of MTs has proved to be a 
real challenge owing to their dynamical conformations that makes crystallization 
difficult, impossible in most cases.
9
  A major step forward in understanding the 
chemical/biological properties of MTs was determining the atomic-level structure of 
fully-metalated MTs by integrating structural information from an X-ray crystal 
structure (rat MT-2A) by Stout et al.
34
 and NMR structures (rat, rabbit, and human MT-
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2A) by Wüthrich et al.
35-37
 They assigned a dumbbell-shaped three-dimensional structure 
to human Cd7MT-2A protein comprising two distinct metal binding domains denoted as 
Cd3- and Cd4-domains.
37,147
  Despite the success in structure determination of fully-
metalated MTs, there is increasing evidence that apo- and partially-metalated species are 
physiologically abundant and may also have important biological roles.
24-25
  However, 
further structural characterization of these metal-unsaturated species has encountered a 
bottleneck.  Blindauer noted that apo- and partially metalated MTs are likely to be 
unfolded to some degree, thus not amenable to traditional structural studies such as X-
ray crystallography.
9
  In addition, many biophysical techniques commonly used for 
characterization of protein conformation are limited to well-defined systems, i.e., 
solutions of pure protein or high quality crystals.  Unfortunately, dynamic equilibria 
between apo- and partially-metalated forms present a significant challenge in terms of 
isolation of individual metalated states from a complex protein pool.  Previous mass 
spectrometry studies have shown that more than six metalation states of CdiMT (or 
ZniMT; i = 0  7) co-exist in solution,
47,107,122,127
 and multiple structural conformers for 
each metalated state adds an additional layer of complexity.  Because traditional 
biophysical techniques measure the average response for the entire system, it is difficult 
or even impossible to resolve signals derived from a single conformer in the presence of 
other closely related conformers from a single metalated state, let alone in the presence 
of multiple metalated states.  In addition, attempts at elucidating structural transitions 
associated with metal binding by circular dichroism (CD) and optical methods such as 
UV/Vis and fluorescence are generally ineffective because mammalian MTs lack well-
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defined secondary structure and they do not contain aromatic amino acids.
9
 FRET 
analysis utilizing labeling at two-termini provides information for change of distance 
between the two sensors,
148-150
 and dynamic light scattering
151
 and small-angle X-ray 
scattering (SAXS) provide information about particle size distribution. However, such 
studies also measure the population-averaged response and do not provide molecule-
specific information, which limits the information content to the comparisons between 
metal-free and fully-metalated states. Therefore for nearly six decades of MT research, 
the only 3-D molecular characterization technique for studies of apo- and partially-
metalated species has been molecular modeling
9
 and comparable experimental evidence 
has been lacking.  Consequently, questions concerning the conformational micro-
heterogeneity of the apo- and partially metalated species or how the distribution of 
conformations changes as a result of metal accumulation remain unanswered and the 
metalation mechanism remains unclear.   
Fenselau and coworkers pioneered the application of electrospray mass 
spectrometry (ESI MS) on studies of MTs.
46-47,91,93-94
 ESI MS is now increasingly used 
for studies of complex biological samples; especially, there is increasing evidence that 
under well-controlled conditions native-like conformations of proteins can be retained 
during the ESI process.
66,152-153
 In our previous study, a combination of chemical 
labeling and top-down and bottom-up proteomic ESI-MS provided valuable new insights 
into the metalation/demetalation of the human metallothionein MT-2A.
127
  The study 
revealed that: (1) metalation of MT by Cd
2+
 occurs by a stepwise mechanism as 
originally suggested by Winge;
126
 (2) partially-metalated Cd4MT is a relatively stable 
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intermediate as supported by a sharp increase in stepwise apparent association constant; 
and (3)  all Cd
2+
 ions are located in the  domain for Cd4MT.
127
   Although the study 
provided a new level of understanding of the metalation mechanism and new 
experimental approaches for probing apparent association constant and location of metal 
ion bound, structures of the metalated species remain unclear.     
Ion mobility mass spectrometry (IM-MS) has emerged as a promising approach 
for characterization of protein conformation, and Guo et al. have reported IM-MS results 
for apo- and fully-metalated Cd7MT.
154
  Here, IM-MS is employed to investigate 
stepwise conformational changes of human MT-2A as a function of the number of Cd
2+
 
ions bound. IM-MS provides an unparalleled approach for monitoring all the distinct MT 
conformers owing to its unique capabilities of (1) separation of the multiple metalated 
states, i.e., the initial apo-protein, intermediates inherent to the metalation reactions, and 
the final products, by their characteristic m/z ratios by mass spectrometry, and (2) 
interrogation of the conformer population for individual metalation state by ion mobility 
spectrometry. Molecular dynamics (MD) simulations are used to generate protein 
conformations whose collision cross section (CCS) can be correlated to the experimental 
IM-MS CCS.  We show here the first experimental data for conformational population 
of each of the metalated forms.  The integrated IM-MS and MD approach offers a global 
view of the conformational changes that occur upon metal binding and provide new 
insights into the metalation mechanism.  
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Experimental  
Materials 
Recombinant human metal-free MT-2A (apoMT) was obtained from Bestenbalt 
LLC (Tallinn, Estonia). Cadmium acetate and ammonium acetate were purchased from 
Sigma-Aldrich (St. Louis, MO). Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-
HCl) was obtained from Thermo Fisher Scientific (Rockford, IL). Deionized water (18.2 
M) was obtained from a Milli-Q water apparatus (Millipore, Billerica, MA). 
Sample preparation 
ApoMT powder samples were prepared and stored using previously described 
procedures.
127
 The sample was then reconstituted to 7 M by 50 mM ammonium acetate 
(pH 7.4) solution containing 1 mM TCEP.  ApoMT is prone to oxidation at 
physiological pH under aerobic conditions, thus TCEP was added to maintain the 
cysteinyl thiols in the active reduced states. The metalation experiment was performed 
by sequential addition of 2, 4, and 6 L of 1 mM cadmium acetate solution to 100 L of 
a 7 M apoMT solution. Following each addition of the Cd2+ solution, the protein was 
allowed to incubate for 1 h prior to MS measurements. Care was taken in all ESI-IM-MS 
experiments reported here to exclude ESI-induced protein oxidation and non-specific 
metal binding as previously described.127   
Ion-mobility-mass spectrometry 
ESI IM-MS measurements were performed on a Waters Synapt G2 HDMS 
instrument (Manchester, UK), a hybrid quadrupole/ion mobility (IM)/orthogonal time-
of-flight mass spectrometer. The samples were analyzed as follows: 7 µM MT solutions 
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were directly infused into the mass spectrometer at a 0.5 µL/min flow rate.  ESI spectra 
were collected in the positive ion mode with a capillary voltage of 1.0  1.5 kV, sample 
cone voltage of 10 V, and extraction cone voltage of 1 V.  The helium cell and nitrogen 
traveling wave (TW) regions were operated at 180 and 60 mL/min flows, respectively.  
A TW velocity of 300 m/s and TW height of 20 V was used for all the experiments 
unless specified otherwise. All mass spectra were calibrated externally using a solution 
of sodium iodide. CCS data were calibrated using ubiquitin, cytochrome C, and 
myoglobin as previously described.128  Abundances of CdiMT
n+ 
were determined by 
performing a baseline correction and calculating the area under the peaks. We also 
evaluated the effect of salt adducts by including salt adducts into the total abundance of 
CdiMT
n+
.  Since the salt adducts are present in all charge states detected, no significant 
difference was observed in the charge state distributions.  
Ion arrival time distribution (ATD) can be very sensitive to experimental 
parameters, especially experimental conditions that may alter the effective ion 
temperature (Teff),
155-157
 and this is especially apparent for apoMT and the partially 
metalated ions.  To illustrate this point, ATD for apoMT
5+
 and Cd7MT
5+
 are shown in 
Figure 4.1.  Note that the CCS profiles differ significantly using conditions that increase 
Teff. Specifically, peaks corresponding to larger CCS peaks are observed in Figure 4.1 A 
and C, but these peaks are attenuated or absent in data taken under conditions that 
minimize ion heating.  All the IM-MS data reported herein were obtained under 
conditions where nitrogen gas flow and the voltages applied to the sample cone, 
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extraction cone, and trap bias were adjusted to minimize ion heating, specifically 
instrument conditions that yield ATDs as shown in Figure 4.1 B and D. 
 
 
 
Figure 4.1.  ATDs for apoMT5+ (A, B) and Cd7MT
5+ (C, D) acquired under different 
instrumental settings. Condition A and C are referred by manufacturer’s suggestion: 
sampling cone 60 V and extraction cone 4 V, IMS gas flow: 90 mL/min and trap bias 45 
V. Condition B and D are operated under a much gentler setting: sampling cone 10 V and 
extraction cone 1 V, IMS gas flow: 60 mL/min voltage and trap bias 35 V. 
 
 
MD simulations 
Due to unavailability of the structure(s) for intact human MT-2A, structures from 
NMR of the separate domains37 were connected (PDB: 1MHU and 2MHU) using a trans 
configuration (backbone dihedral angle  ~ 180°) between the two connecting lysines 
(Lys30-Lys31) as the starting structure for MD simulations of fully metalated Cd7MT.  
Structures for partially metalated CdiMTs (i = 1  6) were generated by placing the Cd
2+ 
600 700 800 900 1000 1100700 800 900 1000 1100 1200
Cd
7
MT
5+
700 800 900 1000 1100 1200 600 700 800 900 1000 1100
apoMT
5+
A
B
C
D
CCS(Å2) CCS(Å2)
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ions in specific bonding sites as indicated in Figure 4.2, which contains the amino acid 
sequence of MT and the numbering scheme of Cd2+ assigned by NMR experiments.37  
Charges on the hydrophilic amino acid side chains, viz. the -amino groups of the lysines 
and the carboxylic acid side chain of aspartic acid and glutamic acid were assigned 
assuming a pH of 7.  That is, cadmium ion is 2+, cadmium coordinated deprotonated 
cysteine is -1, lysine is +1, aspartic and glutamic acids are -1, and free cysteine and other 
amino acids are neutral. We note that there may be other possible Cd2+ configurations for 
the partially metalated forms. For example, Cd2+ may bind cysteines different from those 
designated in Figure 4.2. In addition, the coordination number may not be equal to 4 as 
preferred Cd
2+
 coordination can be either tetrahedral or octahedral.
104  For example, Cd2+ 
ions are octahedrally coordinated in carp parvalbumin, concanavalin A, thermolysin and 
troponin C.
104 However, it is not clear how these variables should be treated because the 
structure, coordination number and site occupancy for partially-metalated MTs have not 
been determined experimentally; therefore, the simulations are limited to previously 
reported Cd2+-S bonding configurations in human Cd7MT (Figure 4.2).   
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Figure 4.2.  Sequence of human MT-2A and its metal-sulfur connectivities. The dotted 
lines denote the Cd2+Cys coordination.  The Cd2+ ions are labeled I  VII using the 
cadmium-thiolate coordination derived from NMR studies.37 The dashed line, , and  
denote the boundaries and locations of the two domains.   
 
 
All-atom MD simulations were performed using AMBER 9.0 FF99SB force 
field, which is extended to include parameters for cadmium–thiolate clusters (parameter 
B2; Table 4.1).158 Solution phase structures were simulated by using a modified 
generalized Born implicit solvent model (igb =5)159 to represent an aqueous solution 
environment.  The initial structures were energy-minimized, followed by simulations at 
300 K in vacuo (solvent-free) or implicit solvent model for 25 or 50 ns.  “Dehydrated 
structures” were generated from solution phase structures by using in vacuo energy 
minimization.45,59,66,160  CCS calculations were carried out using a trajectory method 
implemented in MOBCAL,131 in which the atomic energy and van der Waals radius of 
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Cu2+ were used for Cd2+.  A complete description for MD simulations and data analysis 
is provided in Appendix. Distribution of CCS for each simulation model is represented 
by a histogram with a 10 Å2 interval. The simulated structures were clustered into 
families using a Cα root mean square deviations (RMSD)-based clustering algorithm in 
MMTSB tool set.161 Representative structures, determined as those closer to the centroid 
of each cluster, were selected to represent the candidate experimental structures.   
 
 
 
Table 4.1.  Four candidate force field parameters for Cd2+ ions of Cd7MT.  NB1 and 
NB2 refer to two nonbonded models and B1 and B2 are two bonded models. kb, r0, k, , 
ɛ, and σ denote bond energy, bond distance, angle force constant, bond angle, atomic 
energy, and van der Waals distance, respectively.  
 
Model
Method B2**
BOND kb (kcal mol
-1
 Å
-2
) r0 (Å)
Cd-St 127 2.532 same as B1
Cd-Sb 254 2.596 same as B1
ANGLE k (kcal mol
-1
 rad
-2
)  (degree)
C-S-Cs 46 116.3 same as B1
S-Cd-S 92 109.5 same as B1
Cd-S-Cd 92 120.0 same as B1
Lennard-Jones σ (Å) ɛ(kcal mol-1) σ (Å) ɛ(kcal mol-1) σ (Å) ɛ(kcal mol-1)
Cd 2.48 0.0125 same as B1 2.48 0.25 2.395 0.0395
S 3.92 0.47 same as B1 4.02 0.92 3.92 0.47
Charge
Cd() 2.00
Cd() 2.00
St -0.8844
Sb -0.8844
C -0.2413
H 0.1122
*references: (1) PROTEINS: Structure, Function, and Bioinformatics 2007, 68, 255–266
                   (2) International Journal of Quantum Chemistry, 2001, 83, 230–244
** formal charge from Amber force field
*** reference: International Journal of Quantum Chemistry, 2001, 83, 230–244
**** reference:  J Comput Chem 2009, 30, 191–202
-0.4894
-0.2413
0.1122
1.21
1.21
-0.6869
-0.2413
0.1122
-0.72
-0.02
0.00
-0.72 -0.8844
B1*
Bonded
NB1***
1.285
1.220
2.00
2.00
-0.8844
NB2****
Nonbond
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Results 
The mechanism of metalation of human MT-2A by Cd
2+
 was previously studied 
by ESI-MS.
127
  The ESI mass spectrum of apoMT contains abundant apoMT
n+
 ions that 
range from n = 3  6, but the most abundant ion signals correspond to n = 4 and 5.  
Addition of aliquots of cadmium acetate solution to a solution of apoMT results in 
stepwise addition of Cd
2+
 to form CdiMT, where i ranges from 0  7 (Figure 4.3A).
127
  
A general concern with ESI-MS-based metal-binding studies is the possible occurrence 
of nonspecific interactions. The data indicates that nonspecific Cd
2+ 
association is 
negligible.  Cd
2+ 
was shown to bind only to MT as the concentration of Cd
2+
 increases, 
and not to the non-MT species (impurities present in the original sample) that served as 
reference proteins (see Chapter II, Figure 2.4).  
The ESI charge state distribution of the CdiMT ions shows a dependence on the 
numbers of metal ions (Figure 4.3B), and such changes in charge state distribution could 
be linked to changes in solution phase conformations that alter the solvent accessible 
surface area (vide infra).
162-163
  As the number of metal ions increases, the abundances of 
low charge state ions (n = 3 and 4) increase whereas the abundances of high charge 
states ions (n = 5 and 6) decrease.    
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Figure 4.3. (A) ESI-MS spectra of a 7 M apoMT solution (pH 7.4), and titration of 
apoMT with 20, 40, and 60 M Cd2+. Numbers above peaks denote the metal 
stoichiometry of the CdiMT species (i = 0−7). Data is shown for m/z range of 4
+ ions 
only. Additional peaks at +23 Da (*) and +60 Da (
×
) correspond to sodium and acetate 
adducts.  (B) Charge state distributions of CdiMT (i = 0  7). Relative abundances were 
determined by the areas under the peaks after a baseline correction.  (C) Overlay of CCS 
distributions of CdiMT as a function of metal accumulation. Three charge states 
observed from native electrospray ionization (50 mM ammonium acetate with 1 mM 
TCEP at pH 7.4) are shown in green (3+), red (4+), and blue (5+). Note all the CCS data 
were obtained using ion source and ion transfer conditions that minimize collisional 
heating, which maximizes the preservation of native solution structures. We also note 
that dimeric forms of fully metalated MT species (Cd5Zn2MT, Cd7MT, and Zn7MT) 
have been reported.  Although low abundant dimer ions of partially and fully metalated 
forms (i = 1  7) were observed (6+ dimer ions, see Figure 4.4) under the experimental 
conditions used for this study, the discussion will be limited to the monomeric species. 
(D) Representative in vacuo MD simulations of CdiMT (i = 0  7).  We have considered 
all possible metal ion binding configurations (or metal ion distribution) for each of the 
partially-metalated forms (i = 1  6) except the case of i =4.  Data presented here 
represent one particular configuration with consecutively placing the metal ions into the 
binding pockets using this order: I  V  VII  VI  II  III  IV, the reverse 
demetalation order proposed by the Stillman group.  
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IM-MS provides a direct approach for monitoring the products of reaction 
(speciation) as well as conformational changes that occur upon addition of Cd
2+
 ions.  
Ion mobility CCS data for the CdiMT species are shown in Figure 4.3C; ATD data are 
shown in Figure 4.4.  The CCS profiles for each of the charge states of apoMT span a 
wide range, viz. the 3
+
 and 4
+
 ions range from ~ 700  to ~ 800 Å
2
 and 5
+
 ions range from 
~ 730 to ~ 1100 Å
2
  (Figure 4.3C, top).  We note that the peak widths for apo and 
partially-metalated MT ions are substantially broad (drift time/peak width (DT/PW) ~ 
5.5, 5.2, and 2.7 for apoMT
n+
 (n = 3  5), respectively (see Figure 4.4). This is 
indicative of an ion population composed of a high degree of conformational 
heterogeneity.   In general, the CCS profile for each charge state becomes narrower and 
shifts to lower CCS values as the number of metal ions increases (Figure 4.3C), 
indicating that addition of Cd
2+
 ions yields more compact, ordered conformations.  The 
reduction in conformational diversity and disorder accompanying metal ion addition is 
most pronounced for the CdiMT
5+ ions.  Note that the addition of a single Cd2+ ion 
narrows the peak profile and shifts the CCSs to smaller values, and subsequent addition 
of Cd2+ ions further narrows the CCS profile. The CCS values show consistent decrease 
except for the case from i = 3 to 4, which will be discussed in the discussion section. In 
general, for i ≤ 4, multiple distinct conformations coexist and the population shifts to the 
compact conformers; however, for i > 4, the peak profiles become progressively 
narrower and primarily populate compact conformations. Collectively, the charge state 
distributions and CCS data show that metalation promotes a reduction in conformational 
diversity and yields compact conformations. 
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 Figure 4.4. ATDs of CdiMT
n+ as a function of the number of metal ion bound (i = 0  7) 
in three charge states (n = 3 5). The population at drift time 10.7 ms for the 3+ charge 
state is assigned as dimer of CdiMT as the CCS corresponds to 1155 Å
2
, which 
corresponds to the CCS value of dimer (2
2/3
 times to that of the monomer (730 Å
2
)).45  
Although the dimeric forms of fully metalated MT species (Cd5Zn2MT, Cd7MT, and 
Zn7MT) have been reported, the additional information revealed in our data is that the 
formation of dimer ions is initiated upon metal ion addition to MT and the abundance of 
dimers increases as the number of metal ions bound increases. 
 
 
In an effort to understand detailed molecular features of the conformers observed 
in the IM-MS experiments, in vacuo MD simulations that yield conformations for 
solvent-free, gas phase ions were performed. Independent of the number of metal ions 
added, the simulations of the candidate conformers have a relatively narrow CCS 
distribution centered at ~ 800 Å
2
 (Figure 4.3D).  Although the simulation data are in 
good agreement with that of the compact conformations (3
+
 and 4
+
 ions), the extended 
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conformations (5
+
 ions) observed in the IM-MS experiments clearly show a more 
complicated metalation pathway (Figure 4.3C).  Note that the features for these 
extended conformations remain undetected even when the temperature used for MD 
simulations is increased to 500 K (see Figure 4.5).    
 
 
 
Figure 4.5.  In vacuo MD simulations of apoMT at 300, 310, 320, 350, 400, 450, and 
500 K. The simulations show that, despite the temperature, the conformation equilibrates 
toward compact conformations in a short time ( 1 ns). 
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Ion mobility sample ions that have experienced dramatic changes in their local 
environments, i.e. ions in solution, are ejected as micron size droplets which evaporate to 
yield nanometer size droplets; finally, evaporation of remnant water molecules yields 
solvent-free gas phase ions.
164
  To aid in understanding the effects of desolvation on 
conformer preferences, simulations were carried out using implicit solvent (water) to 
yield solution phase conformations. In an effort to mimic the ESI conditions, the water 
was removed from the MD solution phase conformers followed by energy minimization 
in vacuo to yield what is referred to as “dehydrated” conformers (see Figure 4.6A). The 
differences between gas phase and dehydrated conformations are (1) whether the initial 
conformation is allowed to evolve in bulk water as opposed to a solvent-free 
environment, and (2) whether the energy of conformations are being reduced in the 
simulation process.   The comparison of simulation data in vacuo, in water, and upon 
subsequent dehydration for apoMT is presented in Figure 4.6B.  The in vacuo 
simulation shows that the initial conformer rapidly (within 0.1 ns, trajectory v1) assumes 
a compact conformation that does not change significantly over the 50 ns sampling time 
frame (trajectory v2 represents the equilibrated conformation).  Conversely, sample ions 
obtained from implicit water simulations have CCSs that range from 900  1500 Å2, 
suggesting a wide range of conformers and/or a highly disordered ion population.  The 
labels w1 and w2 represent oscillations between extended and compact conformations 
and w3 represents a conformation having an intermediate size.  “Dehydrated” 
conformations retain the general features of solution phase ions, but the CCS are 
somewhat smaller indicating that the conformers “shrink” in vacuo owing to the loss of 
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water (800  1300 Å2).59,160  The trajectories d1, d2, and d3 resemble the original 
solution conformers w1, w2, and w3, respectively, but the overall conformations are 
refined in vacuum.  Skinner et al. and Silveira et al. recently reported on this 
phenomenon and showed that the “shrinkage” is the result of intramolecular charge 
solvation that occurs upon removal of the solvent.
164-165
   This explanation is consistent 
with arguments that have been used previously to rationalize differences in experimental 
CCS and calculated CCS based on XRD crystal/NMR structures.
59,61
  Histograms of the 
CCSs for the dehydrated conformations of apoMT with formal charges are summarized 
in Figure 4.7 (panel A).  Good agreement was obtained between the simulated 
conformational space (MD) and the range of conformer population (IM-MS). We note 
that effects of charge states for simulations of apoMT are small (data not shown). 
Simulations with manipulating charge states (protonation at Asp2, Asp11, Glu23, or 
Asp55) reveal similar structural fluctuation (open-close motions for solution phase and 
dehydrated structures) and similar conformational space for dehydrated structures (800  
1300 Å
2
, data not shown).  
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Figure 4.6. (A) Schematic representation of MD simulations in three models: in vacuo, 
implicit solvent (water), dehydration.  In vacuo simulations generate the gas phase 
conformations and implicit water simulations were used to generate solution phase 
conformations.  Subsequent dehydration from the solution phase conformations was 
performed by energy minimization in vacuo to generate the dehydrated conformation.  
(B) MD simulations of apoMT.  Structure I corresponds to initial structure of apoMT 
obtained from NMR structure (Cd7MT) after removal of all metal ions.  Trajectories v1 
and v2 are snapshots after simulation in vacuo for 0.05 and 33.2 ns, respectively. 
Trajectories w1, w2, and w3 are time-evolution structures after 1.0, 6.5, and 33.2 ns in 
water. Trajectories d1, d2, and d3 are dehydrated structures from solution structure w1, 
w2, and w3, respectively.  
 81 
 
 
 
Figure 4.7. Histograms of CCS for simulated dehydrated structures. Time evolution 
simulation profiles for gas phase, solution phase and dehydrated structures are provided 
in Figure 4.8.  The simulations were performed on eighteen MT conformers (A  R) that 
includes conformers with different metal ion composition as well as different metal ion 
binding sites.  The domain and specific location of metal ions are indicated on the right 
of the histograms.  ESI-IM-MS data for the three charge states (3+: green, 4+: red, and 
5+: blue) are shown above the histograms.   
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Figure 4.8.  MD simulations for CdiMT (i = 0  7) at 300 K.  Eighteen functional forms 
of MT (conformers A  R) were simulated, ranging from conformers with different 
metalation composition (i = 0  7) to those with different metal ion binding sites.  The 
detailed metal ion configuration for each conformer is listed in each panel, including 
metal composition, specific binding sites of metal ion(s), domain location of the metal 
ion(s), and overall charge state).  For conformers with the same metal composition but 
different metalation configuration, one of the conformers was selected for 50-ns MD 
simulations while others were calculated for 25 ns.  The dehydrated structures were 
further analyzed based on structural similarity by MMTSB clustering toolset. The 
structure with minimal C-RMSD for each cluster is chosen as the representative 
structure. The data for each conformer contains (1) simulations using three models: in 
vacuo, implicit solvent, and dehydration, (2) overlay of histogram of CCS for the 
dehydrated structures (gray) and distribution of clusters (colored dashed lines), and (3) 
representative structures and corresponding CCS for each cluster.   
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Figure 4.8 (Continued) 
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Figure 4.8 (Continued) 
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Figure 4.8 (Continued)  
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Figure 4.8 (Continued) 
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MD simulations were used to examine conformational changes that accompany 
metal ion Cd
2+
 ion binding.  The simulations were performed by adding Cd
2+
 ions to 
specific sites according to the numbering scheme as first proposed by Wüthrich (Figure 
4.2).
37
  Our previous study clearly showed that Cd4MT is a stable intermediate and that 
all four of the metal ions are located in the -domain;127  however, the Cd4MT product 
represents the stable product of metalation and its formation does not dictate that the 
initial metal ion addition is limited to the -domain.  Consequently, there remain 
ambiguities regarding metalation sequence and metal ion binding site(s) in partially 
metalated species, especially for the CdiMT (i = 1 – 3). As the apo- and partially-
metalated MTs are proposed to be disordered, it is more likely all the binding sites are 
exposed and accessible for metal binding.  In addition, the broad range of CCS for these 
partially-metalated forms (Figure 4.3C) provide strong evidence for multiple 
conformers, which most likely differ in terms of metal ion binding sites.  Although it is 
difficult to design experiments that unequivocally resolve such issues, it should be 
possible to probe this further by using MD simulations to generate candidate conformers 
for partially-metalated CdiMT (i = 1  6) and compare predicted and experimentally 
measured CCS.   
Figure 4.7 contains data for conformers generated by simulation that have metal 
ions located in different domains and different binding sites. The complete set of 
simulation data are shown in Figure 4.8.  The CCS distributions for dehydrated 
conformations span the range of 800  1200 Å2 (Figure 4.7). These data show that a 
single metal ion configuration can adopt multiple conformational states. For example, 
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for i = 1, the conformer with Cd
2+
 ion bound at site I yields two distinct populations of 
conformers (B; Figure 4.7).  In addition, the conformers with Cd
2+
 bound in different 
binding sites can yield different conformational preference; note that for i =1, the B 
conformers have smaller CCSs than the C conformer (metal bound at site II).  The 
difference in CCS for CdiMTs with Cd
2+
 bound to different sites decreases as the 
number of metal ions increases; presumably the species having a greater number of 
bound metal ions are folded or partially folded, which limits the numbers of conformer 
states.  That is, for i > 3, the conformers with different metal distribution yield smaller 
difference in their conformational states, and for i = 7, the CCS narrows to a single 
population.  
The comparison between CCS for MD generated conformers and experimental 
CCS suggests that the compact conformers observed in IM-MS experiments (CdiMT
3+
 
and CdiMT
4+
 ions) agree quite well with the gas phase conformers (Figure 4.3D) and/or 
the compact states of the dehydrated conformers (Figure 4.7), whereas the extended 
conformers (CdiMT
5+
 ions) agree best with the dehydrated conformers.  Clearly, the 
simulations appear to overestimate the CCS for the metalated forms and the deviation 
increases as the number of the metal ions increases (max error < 13%).  Although not 
fully understood, the reason(s) for this discrepancy could be attributed to error in 
calibration of traveling-wave CCS,
166
 intrinsic errors in MD and MOBCAL 
calculation,
167
 and most likely the parameters of d-block metal ion (Cd
2+
) used in 
AMBER force field and trajectory method, which remains an underdeveloped area in 
MD simulations and CCS calculation.
168-169
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Figure 4.9 contains MD simulation-generated representative conformers for gas 
phase and dehydrated CdiMT species (i = 0  7); detailed structural clusters and all 
representative conformations are provided in Figure 4.8.  Although the gas phase 
simulations favor compact conformations for all the CdiMT ions, the dehydrated 
simulations represent a broad range of conformer populations. For example, the 
simulation for apoMT yields six distinct conformations. The compact conformer (CCS ~ 
825 Å
2
) matches a globular conformation whereas the other conformers in the range of 
CCSs from 880  1030 Å2 display a greater extent of unfolding.  Binding of the metal 
ions promotes protein folding in the region around the metal ions whereas other regions 
not involved in metal binding remain dynamic. Addition of a single Cd
2+
 ion yields 
globular-like conformers where the domain involved in metal binding appears to be 
partially folded while the other domain appears less ordered. Conformers of species with 
i = 2  3 are more ordered but the majority of the protein backbone remains unstructured 
and dynamic. We noted that the conformers with distinct structures may yield similar 
CCS. For example, at i = 2, conformers with CCS of 945 and 965 Å
2
 are clearly different 
in terms of metal ion configuration and protein structure. At i = 4, three representative 
conformers contain a fully folded -domain with structural variation that arises from the 
extent of unfolding in the -domains.  In the case of i = 5  6, the region of inter-domain 
linker remains disordered and results in several conformers that differ only in the project 
of the - and -domain.  At i = 7, the simulation yields a single conformation that 
corresponds to the well-known dumbbell-shaped structure. 
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Figure 4.9. Representative structures of CdiMT (i = 0  7) in (A) gas phase and (B) 
solution phase. Numbers underneath the conformations correspond to the calculated 
CCS.   
 
 
Discussion  
IM-MS is now widely used for determination of collision cross sections (CCS) 
and conformational heterogeneity of peptide/protein ions; however, there are few studies 
where the ion-neutral CCS of native-like states are correlated to 3-D shapes and 
conformations generated by MD simulations.
45,61-62,66-67,157,170
 An advantage of IM-MS is 
that it is a ‘label-free’ methodology that can be used to characterize protein 
conformations and track conformational changes without need for intrinsic or external 
spectroscopic probes (fluorophore and secondary structures),
45,171
 even proteins with 
conformational micro-heterogeneities including folding of an intrinsically disordered 
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protein.
60
 Most importantly, conformation information provided by IM-MS is molecule-
specific, which permits the characterization of each metalated state in a dynamic, 
complex system.  
The CCS profiles obtained from the centroid of the CdiMT
3+
 and CdiMT
4+
 ions 
are significantly smaller than that for the CdiMT
5+
, and there may be multiple reasons for 
these differences.  Although high charge states are subject to coulombic repulsion that 
could result in increases in protein size and CCS, it is more likely that the CCS for the 5
+
 
charge state originates from disordered solution phase conformations.
163,172
  That is, the 
solution conformers exhibiting lower solvent-accessible surface area (compact 
conformers) give rise to the lower charge states and smaller CCS in gas phase, whereas 
the conformers having higher solvent accessible area (extended conformers) yield higher 
charge states and larger CCS. 
MD simulations suggest that apoMT shifts rapidly between extended and 
globular-like conformations in solution (Figure 4.6B). Further structural analysis on 
these simulated structures shows that all potential hydrogen bonds appear to be transient 
with < 30 % frequencies (Table 4.2), suggesting that apoMT is highly dynamic and 
conformationally disordered in the bulk solution.  Indeed, examination of the amino acid 
sequence of MT shows a compositional preference for small and hydrophilic amino 
acids and a lack of bulky hydrophobic and aromatic residues, which may prevent 
proteins from adopting a stable globular fold.
9
  Complementary ESI techniques reveal 
similar structural information from hydrogen/deuterium exchange and proteolytic 
digestion, i.e., apoMT is rapidly digested (trypsin) to peptides within 5 min and nearly 
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all hydrogens are exchanged instantly (data not shown).  However, the above-mentioned 
methods do not provide information on conformation population.  Ion mobility provides 
a direct measure for the conformational distribution; the IM-MS data suggest that 
apoMT comprises a highly heterogeneous ensemble that populates between CCS 750 Å
2
 
(globular-like compact conformation) and 1050Å
2 
(coil-rich extended conformations, 
Figure 4.9).   The data are consistent with the proposed disordered character of apoMT 
in solution, suggesting that the disorder features could be retained even in the absence of 
bulk water.  This shows that IM-MS is capable of probing conformation population even 
for an “unstructured” protein.66  
The simulation and experimental data for apoMT agree quite well in terms of the 
range of conformation population; however, these two sets of data do not show 
quantitative agreement with the overall CCS profiles viz. the abundances of the 
numerous microstates (Figure 4.7, panel A).  The discrepancy can be explained as 
follows.  The simulated profiles could be affected by the initial conformations, sampling 
methods and length of sampling times used to generate solution phase conformers and 
dehydrated conformations.  Consequently, it is important to note that although the MD 
simulations are very effective for protein conformation searches, they provide largely 
qualitative data and only serve as predictors for the possible conformations. That is, MD 
simulations are used to provide candidate conformation for the conformational states 
observed experimentally.  On the other hand, the experimental CCS profiles represent a 
composite of a number of specific conformations that are formed by the ESI dehydration 
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process and could also be complicated by some degree of collisional ion activation even 
though great care was taken to sample the ions as gently as possible.   
 
 
 
Table 4.2. Hydrogen bond analysis of trajectories of apoMT obtained from 50-ns MD 
simulation in implicit water model.  The data suggest all potential hydrogen bonds 
appear to be transient. 
 
 
ESI charge-state distributions have been directly linked to solution phase 
conformations because there is a strong correlation between observed charge states and 
  H-bond:  X-H---Y
Residue amino acid Y* Residue amino acid H* X*
2 Asp OD1 4 Asn HD22 ND2 27.21 2.801
2 Asp OD2 4 Asn HD22 ND2 17.50 2.803
23 Glu OE2 20 Lys HZ1 NZ 10.45 2.783
2 Asp OD2 20 Lys HZ3 NZ 9.24 2.819
23 Glu OE1 20 Lys HZ1 NZ 8.55 2.783
2 Asp OD1 20 Lys HZ3 NZ 8.46 2.820
23 Glu OE1 20 Lys HZ3 NZ 8.02 2.786
28 Ser OG 20 Lys HZ2 NZ 7.26 2.877
10 Gly O 14 Thr HG1 OG1 7.19 2.811
2 Asp OD2 20 Lys HZ2 NZ 7.01 2.813
11 Asp OD1 31 Lys HZ2 NZ 6.90 2.816
11 Asp OD1 31 Lys HZ1 NZ 6.90 2.811
17 Gly O 46 Gln HE21 NE2 6.55 2.855
11 Asp OD1 31 Lys HZ3 NZ 6.24 2.811
55 Asp OD2 56 Lys HZ1 NZ 6.23 2.819
11 Asp OD2 31 Lys HZ3 NZ 5.87 2.816
55 Asp OD2 56 Lys HZ3 NZ 5.57 2.822
11 Asp OD2 31 Lys HZ2 NZ 5.48 2.814
55 Asp OD1 56 Lys HZ2 NZ 5.44 2.816
55 Asp OD1 56 Lys HZ3 NZ 5.34 2.817
55 Asp OD2 56 Lys HZ2 NZ 5.24 2.817
55 Asp OD1 56 Lys HZ1 NZ 5.11 2.810
23 Glu OE2 20 Lys HZ2 NZ 5.06 2.791
* H, X, Y atom names follow standard amino acids in AMBER
DONOR ACCEPTOR
Frequency (%) Distance (Å)
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solvent accessible surface area.
162-163
   Shifts in the charge state distribution upon 
addition of Cd
2+
 ions to MT (Figure 4.3B) could be viewed as evidence that 
coordination of Cd
2+
 to MT induces conformational changes; however, IM-MS CCS and 
MD simulations provide even stronger evidence of the metal-induced conformational 
changes.  The CCS profiles (Figure 4.3C) show a marked shift to smaller values and 
reduction in peak width as the number of metal ions increases, implying that metalation 
favors more compact, ordered conformations. Although apoMT shows a wide range of 
conformational states, binding of a single Cd
2+
 ion induces reduction in accessible 
surface area as evidenced by changes in the charge state distribution and protein ion size 
(decreased CCS).  Subsequent addition of Cd
2+
 ions promotes further changes in charge 
state distributions and reduction in protein ion size; however, the regions of the protein 
backbone that are not directly involved in metal binding remain disordered as indicated 
by the peak tailing to higher CCS profiles.   
It is somewhat surprising that the marked changes in CCS profiles are observed 
upon addition of a single Cd
2+
 ion (Figure 4.3C).  Shifts in the CCS profiles for the 
stepwise addition of 1, 2 and 3 Cd
2+
 ions are indicative of formation of more compact 
conformers and an ion population that is composed of multiple conformational states.  
The comparison between experimental and theoretical CCSs (Figure 4.7) suggests that 
the broad ion populations for CdiMT (i = 1  3) are likely attributed not only to multiple 
conformational preferences of a single metal ion configuration but also to multiple 
conformers with different binding sites of metal ions. Our earlier study showed clear 
evidence that the metal ions of Cd4MT are exclusively located in the  domain.
127
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Therefore, it is highly probable that Cd
2+
 ions are initially bound to a number of sites and 
then shuttled to more thermodynamically stable sites.  In addition, the CCS for the entire 
ion population shows consistent decrease as the number of metal ions bound increases 
except for the case from i = 3 to 4 (Figure 4.3C; abundances of conformers at CCS 850 
 1000 Å2 increase), which provides evidence for a distinct transition of conformation. 
Although the reason(s) is not fully identified, the data could possibly be correlated to 
metal swapping to the  domain (Cd4MT) from conformations in which metal ions are 
present in both domains (Cd3MT).  This model suggests that the metalation mechanism 
of Cd
2+
 is probably similar to that of Co
2+
 proposed by Vasak and Petering.
33,173
  We 
note that the proposed metalation model is derived from thermodynamic partially-
metalated products under equilibrated conditions, which might be different from that 
based on the kinetic products.    
In the case of i = 4,  the  domain is fully folded,127 thus the empty -domain is 
most likely highly disordered. Indeed, the MD simulation suggests that the distinct 
conformations for Cd4MT can be attributed to a different orientation of the -domain 
(Figure 4.9).  As Cd
2+
 ions bind to the -domain, i.e., i = 5  6, the conformational 
heterogeneity decreases (CCS profiles become more narrow) indicative of formation of 
compact conformers. That is, the population(s) corresponding to conformers that have 
elongated inter-domain linkers (CCS 800 – 950 Å2) decreases as the number of Cd2+ 
increases.  At i = 7, both CCSs obtained from the IM-MS and MD narrow to a single 
population that is consistent with the previously suggested dumbbell-shaped structure.
37
  
Collectively, the data show that metal-induced folding of MT occurs through multiple 
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pathways and involves transitions from disordered-to-ordered, extended-to-compact 
conformational transition.   
In addition to the conformation information provided by IMS/MD data, the ESI 
MS provides valuable information for relative stabilities for each metalated form.
127
  We 
have previously reported the ratio of apparent binding constants for the stepwise metal-
binding, K1:K2:K3:K4:K5:K6:K7 = 15:3.0:1.0:16:3.2:1.0:3.9 for human MT-2A
127
 that 
indicates Cd4MT is a relatively stable intermediate. The relative distribution of the 
CdiMT observed in these experiments is different from what was reported in Stillman’s 
work that proposed a noncooperative manner of binding between Cd
2+
 and human MT-
1A.
120,174
 Although the reason(s) for this discrepancy are not fully identified, it could be 
attributed to slightly different sample preparation and ESI conditions used. In Stillman’s 
work, samples were incubated under argon and capillary voltage used was 3  4.2 kV 
ESI; in our study, samples were in the presence of TCEP and ~ 1  1.5 kV capillary 
voltage was used to minimize the possibility of ESI-induced oxidation. The discrepancy 
could also be due to different isoforms analyzed, as there is increasing awareness that the 
metal-binding properties of one isoform can not be directly applied to that of other 
isoforms.
175
 The IM-MS and MD simulations provide new information for 
understanding the metalation mechanism of MT-2A.  The large value for K1 is attributed 
to the disordered apoMT that presents solvent-exposed cysteinyl sulfur groups thereby 
accelerating reactivity to metal ion(s).  The decrease in values  from K1  K3 and K4  
K6 are consistent with conformational changes that occur as the number of bound metal 
increases, in line with a model proposed by Stillman.
49
  Specifically, the binding of 
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metal ions induces protein folding and inverts the active cysteinyl sites from the protein 
surface to the protein interior.
49
  These structural changes potentially relocate the 
remaining active cysteinyl sulfur groups thereby decreasing their accessibility/reactivity 
toward incoming metal ions.
176-177
   The sharp increase in K4 is linked to a large-scale 
conformational change that accompanies metal ion rearrangement (swapping) that shifts 
the equilibrium from a less stable Cd4MT (metal ions located in both domains) to a more 
stable conformation that has all four metal ions located in the -domain. 
 
Conclusion  
Here, the first experimental data describing the effect of stepwise metalation on 
the conformation of human MT-2A is reported.  The changes in ESI charge state 
distribution for metal-free partially metalated to fully metalated states are attributed to 
successive decreases in the solvent accessible surface area.  IM-MS and MD data clearly 
show that the metal-free protein is conformationally disordered and metalation yields 
compact and ordered conformations.  The partially-metalated forms populate multiple 
conformational states that reflect conformational multiplicity of the protein backbone 
that do not involve metal binding.  It appears that initial metal-ion binding occurs in both 
the - and - domains, but metal swapping between the - and -domains ultimately 
yields the Cd4MT product ions where the metal ions are isolated to the -domain.
127
 MD 
simulations are consistent with metalation occurring along multi-trajectory pathways, 
with the final products corresponding to compact conformations; however, the partially-
metalated intermediates populate multiple conformational states.  Both experimental and 
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theoretical data support a metalation model where metal binding induces transitions from 
disordered-to-ordered and extended-to-compact conformations. This study provides, for 
the first time, experimental data and possible descriptions of conformations for the 
partially-metalated MTs that could have significant impact on the unknown 
conformational space in the protein folding landscape of MTs and serve as a model for 
other metalloproteins. 
This study underscores the importance of IM-MS for mapping conformational 
changes of biologically important proteins that are not amenable to study by traditional 
structural techniques. An additional key component of this study is the importance of 
MD simulations for establishing the chemical/biological relevance of the experimental 
data. Most importantly, NMR and X-ray diffraction provide detailed structural 
information for a single metalated (fully-metalated) Cd7MT form, whereas the IM-
MS/MD approach provides a global and dynamic view that shows stepwise metal-
induced conformational transition of an ensemble in terms of their 3° and 4° structure.  It 
is anticipated that this approach could be applied to other complex systems that are 
highly dynamic and/or heterogeneous viz. comprising multiple species and multiple 
conformations in solution.  
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CHAPTER V 
CORRELATING ION-NEUTRAL COLLISION CROSS SECTIONS TO 
PROTEIN NATIVE CONFORMATION AND ENERGY FOLDING LANDSCAPE 
 
Introduction 
The function and activity of cellular proteins is determined by their three-
dimensional (3-D) structure, but correlating function and structure is immensely 
challenging owing to the fact that the native-state(s) of many proteins related to human 
diseases are disordered.
178-180
  A high percentage (~ 40%) of all human proteins are 
partially or completely disordered,
181
 and many intrinsically disordered proteins (IDP) 
play important roles in disease mechanisms,
182-183
 including p53 regulation in cancer 
pathways, amyloid beta (A) and tau protein aggregation in Alzeheimer’s disease, -
synuclein in Parkinson’s disease, and it is proposed that ~80% of cancer-associated and 
~65% of cell-signaling proteins are IDPs.
184
 It is thought that structural flexibility and 
plasticity (disorder) provide functional advantage,
179-180
 which enhances a wide range of 
physiological pathways involving a disorder-to-order structural transition.
185
 
Characterization of IDP is challenging because they are inherently difficult to 
crystallize,
186
 and conformational diversity (disorder)  complicates NMR approaches.
187
 
Consequently, there is increasing interest in developing mass spectrometry-based 
approaches for characterizing IDPs.  Proteomic mass spectrometry (MS) approaches 
combined with hydrogen-deuterium exchange (HDX)
188
 and chemical derivatization
123-
124,189
 provide high throughput, high sensitivity, and versatile strategies for protein 
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identification.
52,190
 These approaches are complemented by combining “native-ESI” and 
ion mobility-mass spectrometry (IM-MS) by providing ion collision cross section (CCS), 
a direct measure of the physical size and shape of the ions, for studies of conformational 
heterogeneity,
55
 elucidation of protein and protein complex conformations,
56-57
 and 
characterization of IDPs.
58-65
 While there is mounting evidence that gas-phase ions 
formed by ESI retain elements of solution-phase structure(s),
170,191
 the extent to which 
gas-phase ion structures correlate to solution-phase structures is largely unknown. 
  ESI is an excellent choice for studies of biomolecules because ions are 
generated directly from solution and the initially generated ions have low internal 
energies. Beauchamp
 
et al. proposed that the ESI produces ions by a “freeze-dried” 
mechanism, i.e., in the final stages of ion formation the ions are cooled by solvent 
evaporation to temperatures of 130-150 K.
192
 It is important to recognize, however, that 
these ions are subsequently warmed by collisions in heated capillaries and/or by 
collisions with background gas as they traverse the IM and MS analyzers.    
Here, we show that the correlation of gas- and solution-phase structures has a 
significant dependence on changes in the ion’s internal energy or “effective ion 
temperature” (Teff) that occur following ion formation. Ubiquitin is an excellent model 
for investigating the effects of Teff on ion mobility CCS because it has been extensively 
studied, both in solution and gas phase as well as by explicit-solvent MD simulations.
193
 
Clemmer et al. noted that ubq
6+
 and ubq
7+
 ions have CCS that are similar to the native 
fold,
194
 and collisional heating of the ions promotes unfolding.
195
 Bowers also showed 
that ubiquitin ions formed by ESI from solutions that stabilize the native state yield 
 101 
 
 
tightly folded solvent-free ions that have CCS that match the sizes of the native state.
196
 
The extensive database of the conformer preference of solution-phase ubiquitin and the 
prior folding/unfolding studies of gas-phase ions provide the foundations for our 
discussion of the dependence of the experimental CCS on Teff. In addition to an ordered 
protein, an intrinsically disordered and less studied protein, human apo-metallothionein-
2A (MT),
9,37
 was selected for this investigation. ApoMT, a small metal-binding protein 
that is similar in size to ubiquitin,
37
 does not exhibit specific secondary/tertiary structural 
features, but the metalated form assumes increased order as the numbers of metal ions 
increase.
2,9,11
 
IM-MS and molecular dynamics (MD) simulations are employed to address the 
question --- how closely related are the structures of ions sampled by IM-MS to the 
“native-conformation” of the solution-phase protein ions? The experiments reveal 
specific effects of various instrumental parameters on CCS. Although this study is 
limited to the TW IM-MS instrument (Synapt G2 HDMS),
197
 the results are applicable to 
all IM-MS instruments. The results clearly show that unintended collisional heating 
alters the Teff, and that such changes in Teff have strong effects on the conformational 
diversity as evidenced by changes in the IM CCS; however, careful attention to 
instrument tuning minimizes these effects and “native-like” conformers can be retained. 
The experimental data are compared with data obtained by MD simulation at different 
temperatures, which provides insights into the extent of retention of solution phase 
structures by IM-MS.  
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Experimental  
Sample preparation 
Bovine ubiquitin (Sigma-Aldrich, St. Louis, MO) was reconstituted to 10 M in 
50 mM ammonium acetate (pH 7.4). ApoMT sample (Bestenbalt LLC, Tallinn, Estonia) 
was reconstituted to 7 μM using 50 mM ammonium acetate (pH 7.4) solution containing 
1 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl; Thermo Fisher 
Scientific, Rockford, IL).
65,127
 Metalated CdiMT (i = 1  7) were obtained by sequential 
addition of 1, 2, 3, 4, 5, 6, and 7 μL of 1 mM of Cd2+ to 100 μL of a 7 μM apoMT 
solution. Care was taken in all ESI-IM-MS experiments reported here to exclude ESI-
induced protein oxidation and non-specific metal binding as previously described.65,127 
Ion mobility-mass spectrometry 
The ESI IM-MS experiments were performed on a Waters Synapt G2 HDMS 
instrument (Manchester, UK).  “Native state” ESI conditions (H2O, buffered at pH ~ 7.4 
by using 50 mM ammonium acetate) were used for the studies described below, and the 
solutions containing the proteins were directly infused into the mass spectrometer at a 
0.5 µL/min flow rate. ESI-MS spectra were acquired in the positive ion mode with a 
capillary voltage of 1.0  1.5 kV. The effects of the changes to voltages applied to the 
sampling cone (SC), extraction cone (EC), and trap bias (TB), as well as gas flow rate to 
the He cell and TW analyzer (N2) on the CCS profiles (see Figure 5.1 for schematic of 
the Synapt G2 HDMS instrument) were investigated. A TW velocity of 550 m/s and TW 
height of 25 V was used for the ubiquitin experiments and 300 m/s and 20 V for MT 
experiments. All mass spectra were calibrated externally using a solution of sodium 
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iodide. CCS were calibrated using solutions of myoglobin, cytochrome C, and ubiquitin 
as previously described.128 
 
 
   
Figure 5.1.  Schematic of the Synapt G2 TW-IMS instrument.  CCS profiles shown in 
Figure 5.2 were acquired by varying helium flow rate to the He chamber positioned at 
the entrance to TW mobility separator, the voltages applied to the individual ion 
focusing elements (SC, EC, and TB) that are used to guide the ions from the ESI emitter 
tip to the entrance of the TW mobility separator; SC refers to the ESI skimmer cone, EC 
denotes the extraction cone and TB denotes the trap bias lense.  N2 gas flow rate to the 
TW mobility separator was also varied, and the range of flow rates is noted across the 
top of Figure 5.2. 
 
 
MD simulations 
The NMR structure of ubiquitin (PDB: 1D3Z) and that of separate  and  
domains of human MT-2A (1MHU and 2MHU)37 were used as starting structures for 
MD simulations. A complete description for MD simulations and parameters for Cd2+ 
ion were described previously.65 The initial structures were energy-minimized, followed 
by simulations in vacuo or by implicit solvent model. To mimic the inherent dehydration 
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in the ESI process, the solution phase structures were subsequently energy minimized in 
vacuo to generate “dehydrated structures”.45,59,66,160 To evaluate the protein 
conformational change caused by ion heating by the IM-MS spectrometer, simulations 
with increasing temperature were performed.  A complete description for MD 
simulations and data analysis is provided in Appendix. The simulated structures were 
clustered using a Cα root mean square deviations (RMSD)-based clustering algorithm in 
MMTSB tool set.161 Representative structures, determined as those closest to the 
centroid of each cluster, were used to represent the candidate experimental structures. 
Temperature map 
The temperature map (Figure 5.2) for ubq
6+
 ions was estimated from the range of 
experimental CCS that were decomposed into multiple conformational families 
(compact: C; intermediate: I; and extended: E) using Origin v8 (OriginLab Corp. 
Northampton, MA). The best fit to the experimental peak profiles was obtained using six 
peaks (see Figure 5.3). The abundances of individual conformations were determined by 
calculating the area under the peaks. Changes in the abundances of each conformer 
clearly evident on Teff were then compared to temperature-dependent MD simulations. A 
strong correlation was obtained between temperature and the value of CCS for the 
simulated trajectories, i.e., conformers C, I and E are produced at different temperatures 
(see Results section). Therefore, the Teff for each experimental condition was estimated 
using “abundance-weighted” CCS that are calculated on the basis of the relative 
population of the C, I, E conformers.  
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Figure 5.2.  CCS profiles for ubq
6+
 ions acquired using a range instrumental tuning 
condition. The values listed as rows a − f are parameters that are applied prior to the 
TW-IMS N2 analyzer and columns 1 − 6 display the effects of N2 flow within the IMS 
cell (90 − 40 mL/min).  The specific regions of the instrument and the notation used in 
(a) − (f) are illustrated in Figure 5.1. The color shading of the CCS profiles are intended 
to show the transition in Teff sampled by the specified instrument tuning conditions, 
where Teff decreases on going from red to blue.  The changes in the relative abundance 
of the conformational states (compact (C), intermediate (I) and extended (E)) of ubq
6+
 
are plotted in (g) for a constant TW N2 flow rate (80 mL/min) and similar plots shown in 
(h) were obtained by at parameters (a), (d) and (f) while varying the N2 flow rate to the 
TW analyzer.  The temperature map was generated to illustrate the extent of ion heating 
for each experimental condition. 
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Figure 5.3.  (A) Representative ESI MS spectrum of ubiquitin in 50 mM ammonium 
acetate (pH 7.4).  We note that the charge state distribution (CSD) shown here is very 
similar to that reported by Williams and coworkers who also used Synapt G2,
198
 viz. the 
6+ is the most dominate species. However, the MS spectra for ubiquitin under pure 
water reported by Clemmer
199
 and Bowers
196
 using home-built instruments are shifted to 
higher CSD where the 7+ is the most dominant peak. In current study, our data show 
CSDs are similar when different instrumental conditions are used; however, the CCS 
profiles differ significantly. For example, (B) are IMS spectra that are collected using 
parameters (a) – (f) with IMS N2 flow rate of 80 mg/mL (see Results section, main text). 
The CCS profiles are decomposed into multiple Gaussian peaks (dotted lines) using 
Origin 8.0. Best fit was obtained with the use of 6 peaks. Two peaks fall within the range 
of the experimental compact conformer C (CCS ~ 880  ~1000 Å2), another two  
correspond to I (~ 1050  ~1350 Å2), and the other two are E (~1400  ~1600 Å2). 
 
 
Results  
IM-MS of ubiquitin (ubq
6+
) ions   
“Native state” ESI of ubiquitin yields predominately the [ubq + 6H]6+ (ubq6+) ion 
(relative abundance > 75 % abundance; Figure 5.3). CCS profiles for ubq
6+
 ions 
obtained using a range of instrument parameters (see Figure 5.1) are shown in Figure 
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5.2. Although the following discussion is limited to ubq
6+
, data for ubq
7+
 ions are very 
similar to that for ubq
6+
 ions (see Figure 5.4). Note that most of the CCS profiles are 
broad and composed of multiple unresolved signals indicative of an ion population that 
is composed of multiple conformers. Changes in the CCS profiles as a function of 
instrument tuning clearly show that conformational changes are occurring post-ESI, but 
the conformational changes are not reflected in the ESI charge state distribution.  For 
convenience the CCS profiles are divided into three conformer families: compact (C: 
CCS ~ 880  ~1000 Å2), intermediate (I: ~1050  ~1350 Å2), and extended state (E: 
~1400  ~1600 Å2), but it should be noted that each family is composed of 
overlapping/unresolved peaks indicating the presence of multiple similar conformers. 
For example, two distinct E conformations (CCS ~ 1400 Å
2
 (E1) and ~ 1500 Å
2
 (E2)) 
were observed for N2 flow rates of < 50 mL/min of the condition (a) (Figure 5.2a).  
The CCS profile shown in row (a) of column 1 (Figure 5.2) was acquired using 
the manufacturer’s default parameter, which affords the highest ion transmission and 
detection sensitivity, and it is clear that this condition yields the highest abundances of 
ions corresponding to the E state. The CCS profiles in each column reveal a significant 
dependence on the electric field and He flow.  For example, high SC and EC favor the 
extended conformer E, and reducing these potentials yields appreciable abundances of I 
(see (a) – (b)). The effect of TB is illustrated by comparing the data contained in (c) – 
(e), where the most abundant conformers shift from I to C as TB is varied from 45 – 30 
V. The effects of changing the flow rate of He to the He cell is illustrated in (f).  For 
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example, using the same conditions as in (e) but increasing the He flow to the maximum 
(200 mL/min) yields predominately C. 
 
 
 
 
Figure 5.4.  Ion mobility CCS for ubq
7+
 ions electrosprayed from an acidic condition 
(50%:50%:1% MeOH:H2O:Acetic Acid). The CCS data collected using various 
instrumental parameters are shown in a two dimensional matrix. The CCS profiles vary 
significantly. Values of the parameters for the gas flow of He cell (He) and the voltages 
of sampling cone (SC), extraction cone (EC), and trap bias (TB) for the conditions a – f 
are listed in left column of figure: (a) 180 mL/min, 40V, 4V, 45 V; (b) 180 mL/min, 
10V, 1V, 45 V; (c) 180 mL/min, 10V, 1V, 40 V; (d) 180 mL/min, 10V, 1V, 35 V; (e) 
180 mL/min, 10V, 1V, 30 V; (f) 200 mL/min, 10V, 1V, 30 V, respectively. Columns 1 − 
6 show the effects of N2 flow within the IMS cell on CCS, operated with a constant rate 
of 90 (left) through 40 mL/min (right). 
 
 
A quantitative plot that illustrates the effects of the electric fields and the gas 
(He) flow rate to the He cell is represented in Figure 5.2(g), which shows the 
abundances for the three conformer families (E, I and C) at a fixed IMS gas (N2) flow 
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rate (80 ml/min) as a function of parameters for (a) − (f). Note that these parameters 
result in changes in Teff prior to the ions entering the TW IMS analyzer. The results 
show that the sequential decrease of electric field and an increase in He flow (a) – (f) 
favors more compact conformers.  
The CCS profiles also show a significant dependence on the N2 gas flow rate, 
which can be seen by comparing the profiles in each row as the N2 flow rate to the TW 
analyzer is reduced from 90 to 40 mL/min. For example, as the N2 flow rate is reduced 
from 90 to 40 mL/min the profiles in row (a) shift to smaller CCS, transitioning from E1 
to E2 and finally to I. The quantitative data showing changes in the CCS profiles as a 
function N2 flow rate to the TW separator are shown in Figure 5.2(h).  Here, the 
abundances of C, I and E are plotted for various N2 flow rates obtained using instrument 
tuning parameters that favor high, intermediate and low electric fields, conditions (a), 
(d) and (f) in Figure 5.2, respectively. As noted above, conformer(s) E dominates the 
CCS profiles taken using high electric fields (left panel, Figure 5.2(g)) and decreasing 
the N2 flow rate causes a reduction in E with a concomitant increase in the abundance of 
I. The data obtained using intermediate electric fields, i.e., those used for Figure 5.2(d), 
are dominated by I and the abundances of C and E are lower at N2 flow rates of 90 
ml/min, and changing the flow rate (80  70 ml/min) results in an increase in C and 
decreases in both I and E (medium panel, Figure 5.2(g)). The abundances of C and I do 
not change significantly for N2 flow rates of 70  60 ml/min, and further decrease in the 
flow rate (< 60 ml/min) results in an increase in I and concomitant decrease in C. Lastly, 
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the data collected at low electric fields (row f) show that C is favored at N2 flow rates of 
90 − 80 mL/min but the ion population is shifted to I at low gas flow rates. 
IM-MS of human MT-2A   
CCS profiles for apoMT, and the partially- and fully-metalated states (CdiMT
5+
 i 
= 0  7) are shown in Figure 5.5. We previously showed that addition of Cd2+ to MT 
promotes folding as evidenced by increase in the abundances of compact conformers as 
the number of bound metal ions increases.
65
 In that paper we only reported CCS data for 
the CdiMT ions (i = 0 – 7) that were obtained using instrument parameters that 
correspond to a low Teff condition.
65
 The data shown in Figure 5.5 span the same range 
of instrument tuning parameters as discussed above for ubq
6+
 ions. The effects of Teff can 
be seen by comparing the CCS profiles in rows (a)  (e) in Figure 5.5.  That is, (a) 
reports CCS data for ions having high Teff and high ion transfer efficiencies and (e) 
corresponds the condition where lowest Teff is achieved.  As expected the condition (a) 
favors an ion population composed exclusively of extended conformers; however, CCS 
profiles collected at progressively lower Teff (going down each column) contain partially 
resolved conformers or conformer families that are relatively compact. It is interesting to 
note that the CCS profile for apoMT remains highly heterogeneous at the lowest Teff, 
which is further evidence that the protein is indeed best described as an IDP.  Similar 
broad, multi-component CCS profiles are observed for the partially metalated ions, 
especially for i = 1 – 5. We note that the CCS transition collected using the lowest Teff 
(row (e)) corresponds to a transition from disordered to ordered conformation, which is 
consistent with solution studies.
2,9,11
 That is, as the number of Cd
2+
 ions increases there 
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are significant changes in the CCS profiles owing to diminution in the conformer 
population as well as shift to small values in their respective CCS.  On the other hand, 
the effect of binding of metal ions on changes in Teff can be seen by comparing the CCS 
transition between each column, viz. as i increases, greater Teff (greater energy input) is 
required to unfold CdiMT.   
 
 
 
Figure 5.5.  Ion mobility profiles of CdiMT (i = 0 − 7) acquired under various 
instrument conditions. The voltages of sampling cone (SC), extraction cone (EC), trap 
bias (TB), and flow of He and IMS cell were: (a) 60V, 4V, 45V, 180 and 90 mL/min, (b) 
10V, 1V, 45V, 180 and 90 mL/min, (c) 10V, 1V, 35V, 180 and 90 mL/min, (d) 10V, 1V, 
35V, 180 and 70 mL/min, and (e) 10V, 1V, 35V, 200 and 70 mL/min, respectively. 
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MD simulation of ubiquitin and CdiMT (i = 0 – 7)   
Implicit water and in vacuo MD simulations were used to generate candidate 
conformations of ubq
6+
 and apo-, partially- and fully-metalated MT ions. Solution-phase 
structures are then subjected to in vacuo energy minimization to generate dehydrated 
structures.
45,58,66,160
 Simulations for 300 K gas phase and dehydrated ubq
6+
 ions over a 
10-ns window yield globular conformations (Figure 5.6).  The dehydrated ions retain 
solution-phase secondary structure elements, whereas the secondary structure elements 
of the gas phase ions are disrupted. That is, a higher degree of helix and -sheet structure 
is retained in the dehydrated conformers than is observed for the gas-phase ions (see 
Figure 5.6). Regardless, the average CCS of the gas- and solution-phase conformers are 
quite similar, 921.7 ± 6.1 Å
2
 and 934.0 ± 10.1 Å
2
, respectively, and both are in 
reasonable agreement with the experimental value for the compact C conformers.  
Temperature-dependent conformations for solution and in vacuo simulations of 
ubq
6+
 ions are shown in Figure 5.7(a) and (b), respectively. The solution simulations 
were designed to mimic heating that occurs during the droplet evaporation 
accompanying ESI (Figure 5.7(a)), viz. the solution transitions from ~ 300 K to a 
temperature of ~ 425 K; however, the simulations do not account for the evaporative 
cooling that may accompany droplet evaporation.
192
 The calculated CCS for the 
dehydrated structures over the range of temperatures from 300 K to ~ 375 K fall within 
the range of the compact conformer C (~ 950 Å
2
), and as the temperature is increased 
the CCS transition through I (~ 1200 Å
2
) and eventually to E (~ 1500 Å
2
).   
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Figure 5.7(b) contains similar data for gas phase unfolding in a solvent-free 
environment, viz. representative of ion heating in late stages of ESI as well as any 
changes in Teff as the ions traverse the regions of the instrument that guide the ions to the 
TW analyzer. Note that ions from gas phase unfolding have a very different dependence 
on Teff than do the solution phase ions. As temperature increases from ~300 K
 
to 500 K, 
the protein undergoes some compaction with a small loss of 2
o
 structure elements, but 
the changes in CCS are small, ~ 3%. Further increase in Teff (> 600 K) results in 
complete loss of 2
o
 structure elements resulting in formation of largely disordered 
conformations. Specifically, the Teff range for unfolding gas phase ions is much larger 
than that for solution phase ions, and the range of CCS is also much larger for gas phase 
ions.  
The gas phase, hydrated, and dehydrated candidate structures for the various 
CdiMT species were generated as described above for ubiquitin.
65
 Unlike ubiquitin, MT 
is disordered in solution thus the structural evolution at fixed temperatures was 
evaluated. Figure 5.8 shows the time-dependent CCS and representative conformations 
for dehydrated CdiMTs at temperatures 300, 350, and 400 K. The simulation data show a 
good agreement with the experimental CCS and both of them suggest that (i) at 300 K 
the protein disorder decreases as the numbers of Cd
2+
 ions bound increases, (ii) the 
protein unfolds as temperature increases independent of the numbers of Cd
2+
 ions bound, 
and (iii) the transition in CCS for apoMT (disordered protein) is much more sensitive to 
temperature compared to that of Cd7MT (ordered protein).  For example, at 300 − 350 K 
a sharp transition from the compact conformer (CCS ~ 890 Å
2
) to a partially-unfolded 
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conformer (CCS ~ 1100 − 1200 Å2) is evident for i = 0 – 2, but similar transitions are 
less apparent for the i = 3 – 7 ions; however, there is an overall increase in CCS as 
temperature increases. Simulation data for the gas phase CdiMT are provided in Figure 
5.9, and these data clearly show similar unfolding transition as the temperature increases. 
 
 
 
Figure 5.6.  MD simulation of ubiquitin at 300 K. (a) NMR solution structure (1D3Z) 
was used as initial structure for simulation. (b) 10ns-MD simulations of dehydrated 
(blue) and gas phase (black) ubiquitin. The data show that for both cases, the simulation 
assumes compact conformations with an average CCS of 934  10.1 and 922  6.1 Å2 
for dehydrated and gas phase structures, respectively. The representative dehydrated and 
gas phase structures derived from the simulations are shown in (c) and (d), respectively. 
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Figure 5.7.  Simulations of effect of temperature on (a) dehydrated and (b) gas phase 
ubiquitin structure. Dehydrated structures are generated by in vacuo minimization of 
solution structures that underwent thermal unfolding in the presence of water; gas phase 
structures are simulated in the absence of water. 
 
 
 
Figure 5.8. MD simulations of dehydrated CdiMT (i = 0  7) at temperatures of 300, 
350, and 400 K. The time window for each temperature is 5 ns.  
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Figure 5.9. MD simulations for the effect of temperature on gas phase CdiMT structures.  
The simulation data show that irrespective of the number of metal ions bound, the 
protein unfolds as temperature increases; however, the unfolding proceeds much slower 
as the number of metal ions increase, consistent with the experimental data. 
 
 
Discussion 
Heck defines “native-state ESI” as the ability to retain quaternary structure of the 
biomolecule complex,
52
 and Ruotolo’s studies on the collision-induced unfolding (CIU) 
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of small molecules bound to proteins and protein complexes provide additional support 
for Heck’s definition.200 That is, at low Teff the complexes have smaller CCSs than do 
complexes that have been subjected to CIU. Similarly, the experimental CCS profiles for 
ubq
6+
 and CdiMT
5+
 (i = 0 − 7) ions produced by using native-ESI conditions and then 
examined at the lowest possible Teff by IM-MS have CCSs that agree with those for 
solution-phase structures. When these same ions are sampled using conditions 
corresponding to increased Teff, which promote unfolding of the gas-phase ions, their 
CCSs are in excellent agreement with CCSs for candidate structures obtained from the 
temperature-ramped MD simulations.   
The data for ubq
6+
 and CdiMT
5+
 clearly show changes in the conformer 
distributions as the solvent-free ions traverse the instrument between the ESI source and 
the TW analyzer.  Although it is possible that the conformational dynamics are the result 
of slow gas phase refolding processes,
152,201
 the CCS profiles for ions that have the 
lowest Teff (Figure 5.2, columns 1 and 2, row (f)) clearly show that these ions have 
CCSs that resemble to the native fold, suggesting that they do not unfold between ion 
formation and sampling by the TW analyzer. The CCS profile for these lowest Teff ions 
is good evidence that the ESI conditions used for this study produce an ion population 
that is primarily “native”.  Note the CCS for C is in excellent agreement with that of the 
“native-state” CCS for the NMR structure (see Figure 5.6) and that reported by both 
Clemmer and Bowers.
194,196
 Thus, changes in the conformer distribution that are 
reflected by changes in the CCS profiles must be related to changes in Teff that occur 
post-ESI, viz. energetic ion-neutral collisions as the ions are guided by focusing devices 
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from the ion source to the TW analyzer. Previous studies by Williams and DePauw 
clearly show that the Teff of small thermometer ions are sensitive to the TW velocity and 
amplitude;
202-204
 however, the CCS profiles for the protein ions studied here do not show 
significant dependence on the tuning of the TW analyzer (see Figure 5.10).  The 
differences between small and large molecule ions may be attributed to the number of 
degrees-of-freedom into which energy can be channeled,
205
 thus, the effects of changes 
in Teff are expected to be much less for large molecule ions. Although our data clearly 
show that SC, EC, TB and He and N2 flow rates have marked effects on Teff for protein 
ions, we do not find any evidence that ion source temperature or tuning of the TW Trap 
ion guide (flow rate of Ar and wave height and velocity) have any significant effects on 
Teff.   
 
 
 
Figure 5.10. Ion mobility data for ubq
6+
 recorded under various TW conditions: (a) TW 
height is fixed at 25 V when TW velocity varies from 350  950 m/s; (b) TW velocity is 
fixed at 550 m/s when TW height varies from 30  18.5 V. Other instrumental 
parameters were maintained as follows: sampling cone (SC) 10 V, extraction cone (EC) 
1V, trap bias (TB) 35 V, He gas flow 180 mL/min and IMS gas flow 70 mL/min. The 
data suggest that varying the TW height and velocity do not cause observable protein 
conformational change. 
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The temperature map that is superimposed on the ubq
6+
 ion CCS profiles clearly 
shows that changes in SC, EC, TB, and He flow shift the conformer preferences from E 
→ I → C as ions having lower Teff are sampled. Note that the decrease in these 
potentials and increase in the flow rate of He significantly reduce the kinetic energy of 
ions before they enter the IMS (N2) cell thereby resulting in decreases in Teff.  The 
overall trends in the data indicate that the ion population generated by “native-state 
ESI” can be preserved under conditions of low Teff. The temperature map also illustrates 
a complex interplay between Teff and the N2 gas flow rate within the TW analyzer, viz. 
the distribution of conformers can be altered by energetic collisions that occur within the 
TW analyzer. The CCS profiles in the first column of the temperature map (Figure 5.2) 
are a direct measure of the conformer distribution as it enters the TW analyzer, and any 
changes in the conformer distribution that arise as the N2 gas flow rate is decreased is a 
result of cooling/heating by collisions in the TW analyzer. For example, row (a) shows 
the results of cooling the ion population introduced to the TW analyzer by using the 
manufacturer’s “default” settings for SC, EC and TB.  Reducing the N2 flow rate is 
accompanied by a decrease in the relative abundance of E and a corresponding increase 
in I owing to a reduction in Teff.  At the other extreme, row (f), the initial ion population 
is composed primarily of “native” state ubq6+ ions, and decrease in the N2 flow rate 
results in an increased abundance of higher energy conformers owing to increased Teff 
relative to the initial Teff for the ions that enter the TW analyzer.  In summary, ions 
entering the TW analyzer with high Teff are cooled as the ratio of N2 is reduced, whereas 
ions entering the TW with low Teff are heated under these same conditions. The data in 
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rows (b) − (e) show that under these conditions Teff initially decreases and then 
increases. Note that the CCS profiles along the diagonal from bottom-left to top-right 
appear to correspond to tuning conditions that favor the lowest Teff for each row (Figure 
5.2).  This observation raises important questions---why does the flow rate of N2 have 
such a dramatic effect on conformer distribution--- how do decreases of N2 flow achieve 
opposite effects (cooling or heating) that are dependent on initial conditions?  First, 
using high flow rates of N2 the He leak rate (into N2 TW cell) will be small, but it will 
increase as the N2 flow rate is reduced.  Under the conditions the flow of N2 is reduced, 
the ratio of He/N2 in the TW analyzer increases, and the increased partial pressure of the 
lighter collision partner (He) reduces energy transfer by the ion-neutral collisions.
205
 
Second, the mean-free-path of ions within the IMS cell increases as the flow of N2 is 
reduced, thus increasing the kinetic energy gained by each collision event. Note that the 
combination of these two effects determines the Teff of the ions. In our experiments, 
using strong ion focusing conditions (row (a)) ions acquire substantial kinetic energy 
prior entering to the IMS cell and this large kinetic energy is converted into internal 
vibrational energy or Teff by energetic collisions at the entrance of the IMS cell and 
dominates the overall Teff of the ions; however, the ions are cooled as the ratio of He/N2 
increases (N2 is varied from 90 – 40 mg/mL). In cases of low electric fields (row (f)) 
where ions do not acquire appreciable amounts of kinetic energy prior to entering the 
IMS cell, the increase in Teff at the entrance of the TW analyzer is expected relatively 
small, thus the overall Teff is dominated by the slow heating within the IMS cell. Lastly, 
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the changes of Teff at the intermediate electric fields (row (d)) are governed by both 
factors. 
Unlike ubiquitin, apoMT is disordered in solution, but the effects of changes in 
Teff are quite similar. That is, the CCS profiles for apoMT
5+
 (first column of Figure 5.5) 
clearly show that an extended conformation is favored at the highest Teff; however, 
decreasing Teff (top-to-bottom, first column) shifts the CCS profile and produces 
partially resolved peaks, indicative of an ion population that is composed of multiple 
conformer families. In addition, the CCS profiles for the partially- and fully-metalated 
CdiMT ions are shifted owing to a higher degree of order as metal ions are added. The 
increased conformational order is a direct result of strong metal-thiolate binding that 
stabilizes the protein structure.  For example, the CCS profile for the highly ordered 
Cd7MT
5+
 ion is multi-component even at high Teff, but it eventually converges to a single 
compact conformer (bottom row of column 8). Similar trends are also observed for all 
the apo- and partially-metalated forms.  
Although all of the CdiMT
5+
 ions unfold as Teff is increased, their Teff-dependent 
unfolding is quite different. For example, Cd7MT
5+
 maintains the native-like fold at 
medium Teff (condition c) but under the same conditions the apoMT
5+
 is significantly 
activated and composed of a single elongated conformation (Figure 5.5). This 
differential Teff-dependent unfolding observed for apoMT
5+
 and CdiMT
5+
 ions is 
attributed to differing degrees of stabilization by intramolecular interaction, i.e., the 
presence of strong metal-thiolate interaction introduced by the binding of metal ion 
makes protein ions more resistant to ion heating.  
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There are two potential approaches that can be used to probe folding/unfolding 
pathways of gas phase ions as a function of Teff and or time: (i) IM-MS
195,206-207
 and (ii) 
electron-capture dissociation (ECD) combined with hydrogen/deuterium exchange 
(HDX).
165,201,208
  Here, MD simulations are used to generate Teff-dependent conformer 
preferences.
209-210
 The data contained in Figure 5.7 illustrate that ion heating in water 
and in the gas phase gradually depletes the protein 2° and 3° structures, and these 
processes form multiple intermediates that involve formation of the elongated 
conformers. However, the unfolding pathways are distinct between the two models: (i) 
the partially unfolded I conformers differ significantly, viz. the dehydrated structures 
retain the 2° structures of the native fold for a longer period of time, whereas these 
interactions are disrupted very quickly for the gas-phase ions; (ii) the unfolding in gas 
phase ions proceeds much more slowly and results in a much broader dispersion in CCS, 
probably owing to the strong intramolecular electrostatic interaction (charge solvation) 
in the absence of water.   
The simulated Teff-dependent conformer preferences are consistent with the 
experimental data.  That is, a structural transition from compact to extended 
conformations is observed for both ubq
6+ 
and CdiMT
5+
 ions; however, it should be noted 
that the simulation data presented here only represent possible unfolding pathways and 
there are many possible parallel pathways to the energetically accessible unfolded 
states.
165,208
 
The Teff-dependent conformational changes provide important insights into the 
protein energy folding landscape. To date, very little is known about the effects of 
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metalation on folding/unfolding of metalloproteins.
9
 The solution phase-like 
conformational landscape is best represented by the CCS data collected with minimal 
energy perturbation. For example, the CCS data for apoMT is consistent with that of an 
intrinsically disordered protein (IDP), i.e., an energy folding landscape composed of 
multiple energy minima. Addition of metal ions converge the distinct conformation to a 
narrow CCS profile that can be correlated to changes in the folding landscape, i.e., metal 
binding induces new structural domains thereby reducing the flexibility of specific 
domains of the molecule. Such changes result in narrowing of the conformational space 
and deepening of the funnel-shaped landscape. As the number of metal ions bound 
increases, the depth of the funnel increases, in line with the Teff data shown in Figure 
5.5.  For example, the CCS profile for Cd7MT
5+
 appears to be unchanged over the range 
of conditions used to acquire (c) − (e); however, that of apoMT5+ has changed 
dramatically when the same range of conditions is used. Similarly, the Teff data for the 
partially metalated ions, CdiMT
5+
 i = 1 – 6, that are “trapped” in local minima, i.e., 
initially sampled at either low or high Teff, corresponding to (a) or (e), respectively, can 
sample the landscape provided sufficient energy, thus changes in Teff coupled with IMS 
can be used to map the energy folding landscape as a function of degree of metalation.   
 
Conclusion  
 “Native mass spectrometry” is emerging as a powerful technology in structural 
biology and experimental parameters that most strongly affect “Native ESI” are now 
quite well defined;
52
 however, the question how “native” are ions sampled by the IMS 
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experiment remains elusive. That is, there is considerable time lag (10-100 s) between 
ion formation and ions entering the IMS analyzer, and the ions can unfold/refold on this 
time scale.
152
 Also, collisional activation can occur as ions are guided/focused by 
electrostatic lens and ion-neutral collision as they travel from the ions source to the IMS 
analyzer, and Teff can also be increased by black-body irradiation from their 
surroundings.
211
 Clearly, increases in Teff influences protein conformation, thus to what 
extent does the journey from source to IMS analyzer influence conformer preferences of 
large molecule ions, how do these effects influence IMS data, and most importantly, can 
we correlate “native” and “non-native” states sampled by IM-MS to solution “native” 
conformation?  
Here, we clearly show that IMS CCS profiles do not always retain the structural 
feature for the “native” structure when the ions are formed using “native-ESI” 
conditions.  In cases of large proteins or protein complexes, the available experimental 
data support the claims that solution phase structural features are retained; however, TW 
IMS studies for ubq
6+
 ions and drift tube IMS for apoMT
5+ 154
 show that they adopt 
extended conformations
204
 that differ significantly from the native-like state; however, 
data shown in the current study clearly show that under conditions that minimize Teff, 
CCS profiles are consistent with the results reported by solution studies, for both ordered 
(ubiquitin, Cd7MT) and disordered (apoMT) proteins.   
This study serves as a cautionary note for interpreting structural information and 
careful evaluation of the experimental IM-MS parameters prior to assignments of ion 
conformation.  In these studies the conformational changes associated with 2
o
 and 3
o
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structure that are occurring as the ions traverse the instrument are derived from 
cumulative effects of individual ion focusing optics. On the other hand, the data suggest 
that careful tuning of instrumental parameters allows preservation of native-like 
conformation.  This study also helps to define specific tuning guidelines that achieve low 
Teff for the most widely used IM-MS instrument for protein structure and structural 
biology.  
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CHAPTER VI 
CONCLUSIONS 
 
Summary 
Since the discovery of MT in 1957, MTs have been received consistent attention 
in all aspects. Up to now, > 10,000 research articles have been retrieved from Pubmed 
on MT research.  Although extensively studied, the fundamental understanding about 
chemistry of MT-metal ion interaction has not been fully established and there remain 
many unanswered questions.  
ESI-MS has been used in previous studies of MTs, but the experimental 
approaches used in this work reveal new insights regarding metalated/demetalated 
intermediates and reaction mechanism. Direct sequencing of the partially-metalated 
intermediates in the metalation/demetalation reactions provides unambiguous 
identification of the site-specific information regarding the mechanism of 
metalation/demetalation, demonstrating that the binding of metal ion is domain-specific, 
ie. the α domain is formed before the β domain. The relative metal ion-binding affinity 
for individual partially-metalated intermediates provides direct evidence that the Cd
2+
 
ion binding to MT is cooperative. That is, an increased metal ion affinity was observed 
to saturation of the -domain and that of both (- and -) domains. The reverse 
reactions, demetalation by EDTA or metal-ion displacement by NEM, are also 
cooperative. The stable intermediates contain Cd4α-domain in both metalation and 
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demetalation reactions, indicative of a greater thermodynamic and kinetic stability for 
the α domain than that the β domain. 
The competition of cysteine binding sites between NEM and Cd
2+
 ions provides 
information about kinetically labile Cd
2+
-S bonds. The stable partially-alkylated metal-
remaining intermediate contains the alkylation of the nine cysteines in the  domain as 
well as Cys33 reveals a weakly-coordinated site in the -domain. Although the 
biological role of Cys33 has not been identified, the data provide a direct evidence for a 
existence of a weakly binding site in the α domain and suggest that the contribution of an 
individual cysteine to the structure and function of MT is not equal. 
Ion mobility data and MD simulations provide information regarding the 
conformational population and protein folding energy landscape for apo-, partially-, and 
fully-metalated MTs. The data for the CdiMT (i = 0  7) ions reveal a diverse population 
of ion conformations.  In case of apoMT, the data is consistent with is consistent with 
kinetic trapping of an ion population composed of a wide range of conformers, i.e., an 
energy folding landscape composed of multiple energy minima. Upon metal-ion binding, 
the conformational diversity for apoMT and partially-metalated ions converge toward 
ordered, compact conformations as the number of bound Cd2+ ions increase.  The data is 
viewed as an evidence for a disordered-to-ordered conformational transition upon 
binding of metal ions.  
To our best knowledge, our study is the first report identifying metal-binding 
sites of intact partially-metalated intermediate MT directly. The relative binding affinity 
between each metalated form was also resolved for the first time. We also showed the 
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first experimental data for conformational population of each of the metalated forms, 
which provides a global and dynamic view that shows stepwise metal-induced 
conformational transition of an ensemble in terms of their 3° and 4° structure. The 
knowledge provided here provides new insights related to the metalation/demetalation of 
MT, leading to a better understanding of structure-function relationships. 
 
Future Directions 
The work presented here provides a better understanding of the underlying metal-
binding mechanism and structure-function relationship of MTs.  On the other hand, it 
also raises as many questions as it has answered. For example, the distinct properties 
between  and   domain presented here imply the different biological function of the 
two domains: one is regulatory domain and the other one is detoxification domain. The 
domains seem to act independently, then why does MT evolve to a two-domain 
structure? Is there a domain-domain interaction? Does the intra-domain linker (K31-
K32) play a role in intra-domain interaction? A follow-up study on individual domains 
will be needed to answer these questions. Besides, metalated MT is a fairly small protein 
held by two tight metal-thiolate clusters. Is there any critical cysteine that can alter the 
functions and structure of MT dramatically? The reaction with NEM suggests that Cys33 
is less involved in the metal-thiolate cluster. What is the possible role of Cys33? A series 
of mutants with single cysteine replacements and integrated mass spectrometry-based 
approaches will find answers to these questions. 
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APPENDIX 
DETAILED PROCEDURES FOR MD SIMULATIONS 
 
 All-atom MD simulations were performed using Amber 9.0 FF99SB force field, 
which is extended to include parameters for Cd2+ ions (See Table 4.1).  The initial 
structure of Cd7MT was constructed by connecting Cd4 and Cd3 domains (PDB: 
1MHU and 2MHU) using a trans configuration (backbone dihedral angle  ~ 180°) 
between the two connecting lysines (Lys30-Lys31). In case of ubiquitin, solution NMR 
structure (1D3Z) was used as starting structure.  Initial structures of partially-metalated 
and metal-free MTs were obtained by removal of Cd2+ and the corresponding Cd2+-S 
connectivities (See Figure 4.2).  We note that there may be other possible Cd2+ 
configurations in the partially metallated forms. For example, Cd2+ may bind cysteines 
that are different from those designated in Figure 4.2 and the coordination number may 
not equal to four. Nevertheless, the first attempt for our simulations is limited to the 
known Cd2+-S bonding configurations in human Cd7MT.   Initial structures of ubiquitin 
and CdiMTs (i = 0  7) were minimized 5000 steps with infinite cutoff, followed by 
fifty- (or twenty five-) nanosecond production simulations in vacuo or implicit solvent at 
a constant temperature 300 K. The nonbound interaction for production MD simulations 
was set as 12 Å.  For every 5 ps, the simulated structures were saved into trajectory 
coordinates for CCS calculation.  For dehydration, the solution phase structures (every 5 
ps) were treated as the initial structures for in vacuo energy minimization for 100000 
steps.     
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 Transition metal ions constitute a major problem in MD simulations because 
force field parameters for these ions are generally not available.  The specific challenges 
for modeling transition metal ions are: (1) the interaction between metal ion and 
ligand(s) is intermediate between that of non-covalent and covalent bonds; (2) the metal 
ion can have many different types of ligands and number of coordination bonds; and (3) 
quantum mechanical ligand-field, spin-state, Jahn-Teller distortion, and trans effect also 
need to be addressed.  For these reasons, the development of force field parameters for 
transition metal ions has been relatively limited, making MD simulations of 
metalloproteins greatly difficult.  On the other hand, methods for modeling of 
metalloproteins are also underdeveloped. Current approaches usually involve (1) 
defining a covalent bond and a set of interactions between metal ion and ligand atom(s) 
(bonded method) or (2) using nonbonded electrostatic and van der Waals forces 
(nonbonded method), with either formal or partial charge of metal ions and ligands.   
In our study, four candidate cadmium parameters obtained from previous studies 
were evaluated (Table 4.1).  These four Cd2+ parameters were examined using MD 
simulations of Cd7MT in the implicit water model, and choosing the parameter that 
agrees best with experimental data (NMR-determined structure) for production 
simulations. Our emulation suggests that the B2 parameter (bonded method with formal 
charge of cadmium ion) yielded trajectories closest to the ones for the NMR-determined 
structure.    
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We next incorporated Cd2+ into trajectory method in MOBCAL using Cu2+ 
atomic energy and van der Waals distance for Cd2+ (atomic mass = 112.41 Da, atomic 
energy = 1.35 meV, van der Waals distance = 3.5 Å).   Our data show that the range of 
CCS for the simulated structures is ~ 1150  1300 Å2 with an average value 1205  34 
Å
2
, however, this value is 163 Å
2
 larger than that for the NMR-determined structure 
(1042 Å
2
) (data not shown).  The data suggest that our simulation parameters are biased 
and the CCS derived from MD simulation requires correction.   
The reason(s) that the calculations overestimate the CCS (16 %) is not fully 
understood. The error may arise from several factors, including errors associated with 
the calibration for traveling-wave CCS, limitations of structure sampling for classical 
MD, intrinsic errors of MD simulations and trajectory method, capability of classical 
MD algorithms in treating interaction potentials of transition metal ions, and more likely, 
the cadmium parameters in force field and trajectory method since these 
parameters/methods for transition metals have not been thoroughly examined.  We note 
that the simulation data for apoMT show good agreement to the experimental IM-MS 
data (see Chapter IV), suggesting that the errors are most likely associated with the 
parameters for Cd
2+
 ions.  In case of MT, the error may be more pronounced because 
there are seven Cd
2+
 ions on such a small protein. However, developing new parameters 
for Cd2+ is beyond the scope of our study.  Nevertheless, our first attempt to adjust the 
bias (16 %) is to scale CCS values of CdiMT by the number of Cd
2+ and good agreement 
was found between the scaled CCSs and the experimental CCS: 
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2+
cal MD
number of Cd
CCS  = CCS (1- 16%)
7
  
 
In addition to simulation at 300K, we also simulated the effect of temperature on 
protein conformation (see Chapter V). To mimic the effect of temperature on protein 
conformation, the ubiquitin simulations were run over a linear temperature gradient 
using a rate of 20 K/ns. Two scenarios, ion heating in either the presence or absence of 
water, were considered to reflect a different stage in ESI droplet/ion evolution. In the 
case of the ion heating in the presence of water, subsequent dehydration was performed 
by in vacuo minimization for 10000 steps to generate dehydrated structures. The CCS 
for the simulated ubiquitin was calculated using projection approximation (PA) method 
as the trajectory method fails in calculating CCS values for many of the extended 
ubiquitin structures. However, the PA typically underestimate by 15%. We used an 
empirically determined scaling factor determined by Robison et al. to correct all CCS 
value obtained by PA method. The corrected CCSs show a great agreement to our 
experimental CCS data. In case of MTs, 5 ns-simulation was performed at a fixed 
temperature to evaluate the conformational evolution at various temperatures. The effect 
of temperature on CdiMTs (i = 0  7) was simulated from 300 to 2000 K with 50 K 
increments. For dehydration, the solution phase structures (every 10 ps) were treated as 
the initial structures for in vacuo energy minimization for 10000 steps. Trajectory 
method (TM) implanted in MOBCAL is used for CCS calculation for CdiMT. 
 
